Introduction {#s1}
============

Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental disorder characterized by varying degrees of altered social functioning and engagement in repetitive, stereotyped behaviors accompanied by display of narrowed interests (American Psychiatric Association, DSM-V [@B1]). The most recent surveillance data collected in 2008 by the Center for Disease Control\'s Autism and Developmental Disabilities Monitoring Network indicates that approximately 1 in 88 children has an autism spectrum disorder (CDC, [@B9]). The United States Census Bureau in 2006 projected a doubling of the US population aged 65 and older by 2030. Assuming the life expectancy of individuals with ASD is similar to that of the general population, based on current prevalence rates in school aged children, this population increase would result in a prevalence of approximately 700,000 individuals with ASD aged 65 in the next 20 years (Piven and Rabins, [@B71]).

Despite the population statistics indicating a significant number of aged individuals with ASD, studies that investigate the effects of the neurodevelopmental disabilities including ASD, in an aged physiological context are lacking. Due to the paucity and limitations of studies and the expected increase in the aged individuals presenting ASD a multidisciplinary conference was held in March 2010 to identify gaps in knowledge regarding older adults with ASD. The panel concluded that descriptive studies of aging in humans and rodent models were needed (Piven and Rabins, [@B71]). A limited number of human studies have investigated the persistence of the ASD core deficits into adulthood (Ballaban-Gil et al., [@B3]; Seltzer et al., [@B80]; Shattuck et al., [@B81]), childhood factors that are associated with prognosis (Rumsey et al., [@B76]), and outcome studies (Rutter et al., [@B77]; Howlin et al., [@B40]; Renty and Roeyers, [@B74]). Major findings from these studies suggest that language development (Kanner et al., [@B46]) and Intelligence Quotient (IQ) predicts outcome (Lotter, [@B51]; Rumsey et al., [@B76]; Szatmari et al., [@B86]). The ASD diagnosis persists with inconsistent findings about which, if any, core deficits change (Ballaban-Gil et al., [@B3]; Piven et al., [@B70]; Seltzer et al., [@B80]), and that the adults with ASD remain dependent on others (Rutter et al., [@B77]) even if they have a normal IQ (Howlin et al., [@B40]). Despite persistent dependence some studies found that individuals with ASD had improved symptoms over time (Szatmari et al., [@B87]; Piven et al., [@B70]; Seltzer et al., [@B80]). However, a few limitations hinder these early studies of aging in ASD, including study individuals being only 20--30 years old, small sample sizes, and an inability to completely generalize the study findings given the heterogeneity of the population examined (Rumsey et al., [@B76]; Gillberg and Wing, [@B31]; Fombonne et al., [@B29]; Howlin and Moss, [@B41]).

Given the heterogeneous nature of ASD, mouse models have proven to be particularly useful and reliable in elucidating the mechanism of these disorders (Crawley, [@B18]; Moy and Nadler, [@B58]). There are several approaches to ASD mouse models: targeted gene mutations, defects in neurotransmitters or brain regions, inbred strains, and models based on the comorbidity of other human diseases with autism (Crawley, [@B18]). One strain in particular, BTBR T + tf/j, has been shown to be an especially relevant animal model of ASD (Moy et al., [@B59]). Extensive behavioral characterization of the BTBR (black and tan, brachyuric) mouse model has revealed low sociability compared to wildtype strains (Bolivar et al., [@B7]; Moy et al., [@B59]), resistance to change (Moy et al., [@B59]; Moy and Nadler, [@B58]), increased display of self-grooming behavior (Pobbe et al., [@B72]), display of repetitive behaviors (Pearson et al., [@B67]), and reduced display of territorial scent marking (Wohr et al., [@B92]). Furthermore, unusual vocalizations have also been extensively characterized in BTBR mice (Scattoni et al., [@B78], [@B79]), in addition to instances of social avoidance and gaze aversion (Defensor et al., [@B22]). While the autistic-like behavioral phenotype of the young male BTBR mouse has been studied extensively, the effects of age on this ASD-like mouse model have not been elucidated. As aged human autistic tissue samples are limited and the BTBR mouse model is well characterized and widely accepted, we selected this mouse model to study the nature of the ASD phenotype in an aged context. To enhance our understanding of the aged BTBR mouse and to gain further insight into the effects of aging of ASD, we followed our extensive behavioral characterization of the aged BTBR mouse with quantitative proteomic analyses on cortical and hippocampal tissues as these two brain regions have been strongly associated with ASD (Mundy, [@B60]; Nadler et al., [@B62]). We hypothesized that both the behavioral phenotype and proteomic profile would be different between the aged ASD-like mice \[or mice with an abnormal central nervous system (CNS)\] and the aged wildtype mice (or mice with a presumed normal CNS). Our results contribute to our understanding of the effects of aging on an ASD-like mouse model, and it is our hope that further research will enhance our understanding of aging in an abnormal CNS.

Materials and methods {#s2}
=====================

Experimental animals
--------------------

All experimental animal procedures were approved by the Animal Care and Use Committee of the National Institute on Aging, National Institutes of Health. Male BTBR T + tf/J mice (*n* = 8, 15 months of age) and male control wildtype (WT) C57BL6J (*n* = 5, 15 months of age) were housed in the NIA animal facility on a 12 h light and dark cycle from 6 am to 6 pm and received *ad libitum* access to food and water throughout the duration of the study. All behavioral testing described in detail below was performed between the hours of 9 AM and 5 PM. Prior to behavioral testing, animals were moved from the vivarium to an experimental room and given a minimum of 30 min to habituate to the new environment. Between each experimental animal, all apparatuses were wiped down with 70% ethanol followed by D. I. water to prevent any scent retention that could possibly bias the performances of later mice.

Social preference assessment
----------------------------

Social behavior was assessed using a three-chambered sociability apparatus with a protocol modeled after previously established methods (Crawley, [@B18]). In brief, animals were first habituated for 10 min to the three-chambered sociability apparatus (60 × 40 × 22 cm, Stoelting, Wood Dale, IL) free of any stimuli and returned to their home cage for a minimum of 30 min. Prior to the return of the experimental mouse to the chamber for testing, another mouse of the same strain, age, and gender and an inanimate object both housed in identical wire mesh cylinders (15 cm tall, 7 cm in diameter) were placed in opposing compartments of the apparatus. Experimental animals were then returned to the center chamber of the apparatus and were free to choose to interact with either the mouse or object enclosed in the respective wire mesh containers. Interactions were recorded for 10 min and analyzed with ANY-Maze Video Tracking Software (Stoelting). A discrimination index (DI) was calculated that takes into account the relative exploration time spent with either the contained mouse or object: (animal time/total time---object time/total time) × 100. As socially-normal mice show a robust preference for another mouse over an inanimate object, a high DI is reflective of socially-normal behavior while a low DI is indicative of deficits in social functioning.

Novel object preference test
----------------------------

The novel object preference test was performed as described previously (Dere et al., [@B23]; Park et al., [@B65]). In brief, mice were given 10 min to explore a 25 cm^2^ opaque walled box with two identical objects placed equidistant from each other in the center of the box. After 10 min of habituation to the two identical objects was completed, animals were returned to their home cages for a minimum of 30 min. After the habituation task, trained experimenters replaced one of the identical objects with a novel object that had never been seen by the experimental mouse. Experimental animals were then returned to the opaque box and given 10 min in which they were free to interact with either the familiar or novel object. Both the habituation session and testing session were videotaped and the animal\'s behavior automatically tracked by ANY-Maze Video Tracking Software (Stoelting). Discrimination indices were again calculated: (novel time/total time-same time/total time) × 100. A high discrimination index (DI) is indicative of an enhanced ability to preferentially recognize the novel object, suggesting intact memory functioning.

Open field test
---------------

A generalized view of the behavioral characteristics of both experimental and control mice was obtained via an open field test performed as described previously (Holmes et al., [@B38]). In brief, each mouse was placed in a square chamber approximately 0.14 m^2^ in size (Med Associates Inc, St. Albans, VT) and given 10 min to freely explore. Activity Monitor software (Med Associates Inc) automatically recorded multiple parameters over the duration of the 10 min test. Individual data points were then compiled and subsequently analyzed to produce the following measurements: distance traveled, time spent in the peripheral areas of the chamber, time spent in the center area of the chamber, number of ambulatory episodes, and number of jumping episodes. Relative time spent in the periphery vs. the center was calculated for each mouse by dividing the time spent in either the periphery or center by the total exploration time (600 s for all animals).

Light/dark exploration test
---------------------------

The light-dark exploration test was performed as previously described (Chadwick et al., [@B11]) as a means to assess general anxiety behavior. The same square chamber used in the Open field test was again used to complete the Light/Dark exploration test, with the additional insertion of a dark chamber taking up 50% of the area of the entire apparatus (Dark box insert for mouse open field activity, Med Associates Inc). The dark chamber contains a small arched entrance to allow mice to access the dark environment; this entryway was placed toward the center of the apparatus so mice could easily access it. Time spent in either the light or dark compartment was automatically recorded by Activity Monitor software (Med Associates Inc). Relative time spent in the light chamber vs. the dark chamber was calculated for each mouse by dividing the time spent in either the light or the dark by the total exploration time (600 s for all animals).

Elevated plus maze
------------------

General anxiety behavior was also evaluated using an elevated plus maze test as described previously (Chadwick et al., [@B11]). In brief, animals were given 5 min to explore a plus shaped maze raised approximately 36 cm off of the ground. Two of the arms of the maze were enclosed on all sides; two arms remained open for the duration of the test. ANY-Maze Video Tracking Software (Stoelting) was used to record time spent in either the closed or open arms of the apparatus and the relative time spent in the closed or open arms was calculated by dividing the time spent in either arm by the total exploration time (300 s for all animals).

Rota-Rod test
-------------

Motor coordination was evaluated using an accelerating Rota-Rod treadmill (Med. Associates, Inc) as described previously (Bohlen et al., [@B6]). Briefly, mice were given two training sessions on the spinning Rota-Rod apparatus on the day prior to the testing day (the first trial was administered in the morning and the second trial was administered in the afternoon). Each habituation training trial lasted 2 min \[4 revolutions per minute (rpm)\]. On the test day, the mice were placed on the Rota-Rod, which gradually accelerated from 4 to 40 rpm over a 5 min time interval. The test was performed twice per day and the latency to fall was measured and averaged.

Animal euthanization and tissue collection
------------------------------------------

Following completion of behavioral analyses, animals were euthanized via isoflurane overdose (Butler Animal Health Supply, Dublin, OH) as described previously and in accord with approved animal procedures (Chadwick et al., [@B11]). Bodyweight data was collected immediately prior to euthanization for each animal. Hippocampal and cortical brain tissues were snap frozen on dry ice and stored at −80°C until used for further analyses.

Protein digestion, iTRAQ labeling and western blotting
------------------------------------------------------

Protein digestion and iTRAQ labeling were processed according to the iTRAQ protocol (iTRAQ Reagents---8plex: amine-modifying Labeling Reagents for Multiplexed Relative and Absolute Protein Quantitation, ABSciex). All tissue samples (Hippocampus and Cortex; WT and BTBR) were prepared in parallel throughout the labeling procedures. Briefly, 100 μg of protein in each condition was acetone precipitated and resuspended in 20 μL of iTRAQ dissolution buffer (0.5 M triethylammonium bicarbonate (TEAB), ABSciex) containing 0.1% ProteaseMAX detergent (Promega) to denature the proteins. The sample was then reduced by adding iTRAQ Reducing Reagent \[Tris(2-carboxyethyl) phosphine (TCEP), ABSciex\] to a final concentration of 5 mM and incubated at 60°C for 1 h. Subsequently, the sample was alkylated with iTRAQ Cysteine-Blocking Reagent (10 mM methyl methanethiosulfonate (MMTS), ABSciex) for 10 min at room temperature. The protein sample was then digested with 5 μg sequencing-grade trypsin (Promega) per 100 μg protein at 37°C overnight. Labeling of the samples with iTRAQ 8-plex labels was performed at room temperature for 2 h. After labeling, the samples to be compared were mixed and underwent an off-line strong cation exchange (SCX) fractionation (ICAT Cation Exchange Buffer Pack, ABSciex) to 16 fractions to reduce sample complexity. After reversed-phase desalting (C18 tips, Pierce), the samples were re-constituted in water with 0.1% formic acid, then stored at −20°C until LC/MS/MS analysis. Western blotting procedures as described previously (Maudsley et al., [@B56]; Martin et al., [@B52]), were performed using the same protein lysates employed for iTRAQ labeling. Antibodies used were as follows: rabbit anti-BDNF \[(brain-derived neurotrophic factor) Santa Cruz Biotechnology, Santa Cruz CA\], rabbit antiphosphorylated TrkB and TrkB, rabbit anti-phosphorylated Akt and Akt, rabbit antiphosphorylated synapsin 1 and synapsin 1, rabbit anti-spinophilin, rabbit anti-PSD95 and rabbit anti-synaptophysin (Cell signaling technology, Inc., Danvers, MA), mouse anti-NeuN (EMD Millipore Corporation, Billerica, MA) and mouse anti-beta actin (Sigma-Aldrich, St. Louis, MO). Results were quantified and statistical analysis was performed using an unpaired student *t*-test. *p* \< 0.05 was considered statistically significant.

LC/MS/MS analysis
-----------------

Samples were analyzed using an Eksigent NanoLC Ultra 2D (Dublin, CA) and Thermo Fisher Scientific LTQ Orbitrap XL (San Jose, CA). In brief, peptides were first loaded onto a trap cartridge (Agilent), then eluted onto a reversed phase PicoFrit column (New Objective, Woburn, MA) using a linear 120 min gradient of acetonitrile (2--62%) containing 0.1% formic acid at 250 nL/min flowrate. The eluted peptides were sprayed into the LTQ Orbitrap XL. The data-dependent acquisition mode was enabled, and each FTMS MS1 scan (60,000 resolution) was followed by 6 MS2 scans (alternating CID at unit resolution and HCD at 7500 resolution on 3 precursor ions). The spray voltage and ion transfer tube temperature were set at 1.8 kV and 180°C, respectively.

Database search and iTRAQ quantification
----------------------------------------

Proteome Discoverer 1.2 (Thermo Fisher Scientific) was used for protein identification and iTRAQ quantification using Sequest algorithms. The following criteria were followed: SwissProt mouse database; enzyme: trypsin; miscleavages: 2; static modifications: methylthio (+45.988 Da on C), iTRAQ8plex (+304.205 Da on N-terminus and K); dynamic modifications: oxidation (+15.995 Da on M), deamidation (+0.984 Da on N and Q); peptide tolerance as 25 ppm; MS2 tolerance as 0.8 Da. Peptides reported via all search engines were accepted only if they met the false discovery rate of 5%. For iTRAQ quantification, the reporter ion intensities in MS2 spectra (*m*/z 113--121, integration width tolerance 50 mmu) were used to calculate the expression ratios among the different conditions (Hippocampus and Cortex; WT and BTBR).

Bioinformatics analysis
-----------------------

Functional annotational clustering of our proteomic data, i.e., gene ontology (GO), KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis was performed using WebGestalt (<http://bioinfo.vanderbilt.edu/webgestalt/>, 3/2014) as previously described (Chadwick et al., [@B10], [@B11]). In addition Ingenuity Pathway Analysis (<http://Ingenuity.com>, 3/2014) was employed for Canonical Signaling Pathway enrichment investigations. In brief, GO analysis allows for broad clustering of genes into functional groups, while KEGG pathways analysis allows for more specific clustering into signaling pathways (Maudsley et al., [@B55]). Inclusion criteria were set as follows: pathway groups needed to meet a minimum population of two genes from the input experimental set, and also needed to possess a probability significance of enrichment compared to a control background dataset of less than *p* \< 0.05 (hypergeometric test of significance). In addition, Venn diagrams were also constructed to identify common and uniquely altered genes between hippocampus and cortex, using VennPlex (Cai et al., [@B8]), as described previously (Martin et al., [@B53]).

*Textrous!* latent semantic analysis-based investigation
--------------------------------------------------------

*Textrous!* latent semantic analysis was performed as described previously (Chen et al., [@B14]). In brief, corresponding gene symbols were uploaded into *Textrous!* (<http://textrous.irp.nia.nih.gov/>, 3/2014) and then the relevant output indices, i.e., Cosine Similarity, Z-score and *p*-value were extracted. In addition to the direct list-based semantic output both the Collective processing mode (generating hierarchical word-clouds), as well the Individual processing mode (generating symbol-word heatmaps) were applied to provide more nuanced informatic appreciation of the specific input datasets.

Statistical analysis
--------------------

All statistical analyses were conducted using a Student\'s *t*-test (two-tailed with equal variances: GraphPad Prism, version 5.02). *p* \< 0.05 was considered statistically significant throughout the study. Error bars represent 95% confidence interval. All data represent means ± s.e.m. (standard error of mean). ^\*^*p* \< 0.05; ^\*\*^*p* \< 0.01; ^\*\*\*^*p* \< 0.001.

Results {#s3}
=======

ASD-like behavioral phenotype persists in aged BTBR mice
--------------------------------------------------------

Commensurate with an extant ASD phenotype aged BTBR mice demonstrated no sociability preference between an object or another mouse, while WT controls spent significantly more time with another mouse compared to an object (Figure [1A](#F1){ref-type="fig"}). Relative percentage of time spent with either the mouse or the object was used to calculate a social discrimination index \[DI: (novel time/total time-same time/total time) × 100\] (Figure [2B](#F2){ref-type="fig"}). WT and BTBR mice performed similarly in the novel object preference test of learning and memory, with both groups spending significantly more time with a novel object compared to a familiar object (Figures [1C,D](#F1){ref-type="fig"}). Both WT and BTBR mice significantly preferred to explore the peripheral areas of the chamber over the center of the chamber, though the BTBR mice did show a significantly higher preference for the periphery over the center (Figure [1E](#F1){ref-type="fig"}). No significant differences in total distance traveled (Figure [1F](#F1){ref-type="fig"}) or number of ambulatory episodes (Figure [1G](#F1){ref-type="fig"}) were found. BTBR mice however demonstrated significantly less jumping activity compared to WT (Figure [1H](#F1){ref-type="fig"}). In light-dark exploration tests BTBR mice spent significantly more time in the dark chamber compared to the lighted chamber, while WT control mice show no statistical difference in preference for either chamber (Figure [1I](#F1){ref-type="fig"}). In the elevated plus maze test of anxiety, both WT and BTBR mice significantly preferred closed arms to open arms (Figure [1J](#F1){ref-type="fig"}). Motor coordination, assessed using a Rotarod test was similar in both groups (Figure [1K](#F1){ref-type="fig"}).

![**Social function, cognitive ability, general behavior, anxiety and motor coordination in an aged ASD mouse model**. Social preference was assessed using a three-chambered sociability apparatus in aged male BTBR T + tf/j mice and age-sex-matched control mice **(A, B)**. Percentage of time spent exploring both the contained inanimate object and the contained mouse was measured for male BTBR (*n* = 8) and control mice (*n* = 5) **(A)**. A discrimination index (DI) was calculated **(B)** which represents the degree to which experimental or control animals displayed a preference for exploring the contained mouse over the contained inanimate object. Cognitive functioning was assessed via the novel object preference task (NOP) **(C, D)**. Percentage of time spent exploring either a familiar or a novel object was again measured for male BTBR (*n* = 8) and control mice (*n* = 5) **(C)** and a DI was calculated **(D)** with a higher DI indicating an increased ability to discern a novel object from a familiar object. Exploration of an open field apparatus was assessed in male BTBR and control mice was measured with regard to the following parameters: time spent exploring the peripheral or central areas of the apparatus relative to the total amount of time spent exploring **(E)**, total distance traveled **(F)**, number of ambulatory episodes **(G)**, and number of jumps **(H)**. Exploration of the open field apparatus was repeated with a Light/Dark insert add-on and relative time spent in either the light half or the dark half of the chamber was recorded **(I)**. General anxiety was assessed using the elevated plus maze task. For both BTBR T + tf/j mice and age-and sex-matched controls, relative spent in the closed vs. the open arm was recorded as a percentage of total time **(J)**. Finally, motor coordination was assessed using a rotarod apparatus latency to fall was recorded in both BTBR T + tf/j and control mice (**K**, *n* = 5). Data are expressed as means ± s.e.m. Asterisks represent *p*-values as shown: ^\*^*p* \< 0.05, ^\*\*^*p* \< 0.01, ^\*\*\*^*p* \< 0.001. Statistical significance was measured using a Student\'s *t*-test.](fnagi-06-00225-g0001){#F1}

![**Protein expression in wild type and BTBR mouse cortex**. Western blotting was performed using mouse cortical protein lysates **(A)**. Protein levels were measured in BTBR and control mice with respect to the following proteins in the cortex: pro-BDNF **(B)**, mature BDNF **(C)**, phospho-TrkB **(D)**, total TrkB **(E)**, Akt **(F)** phospho-synapsin 1 **(G)**, synapsin 1 **(H)** synaptophysin **(I)**, PSD95 **(J)**, spinophilin **(K)**, Neuronal cell marker NeuN **(L)**. Data are expressed as means ± s.e.m. Asterisks represent *p*-values as shown: ^\*^*p* \< 0.05. Statistical significance was measured using a Student\'s *t*-test, *n* = 3 for each group.](fnagi-06-00225-g0002){#F2}

Altered protein expression in CNS of aged BTBR mice
---------------------------------------------------

Cortical and hippocampal western blotting of proteins, selected for their ability to indicate alterations of neurosynaptic activity, was employed to detect potential expression differences between aged WT and BTBR mice. Our panel of neurosynaptic factors analyzed in cortical tissue is indicated in Figure [2A](#F2){ref-type="fig"}. No significant difference between WT and BTBR pro-BDNF (brain-derived neurotrophic factor) levels was detected (Figure [2B](#F2){ref-type="fig"}), whereas a significant decreased in BTBR mature BDNF was observed compared to WT (Figure [2C](#F2){ref-type="fig"}). Levels of phosphorylated TrkB receptor were similar in WT and BTBR cortex (Figure [2D](#F2){ref-type="fig"}) while the total TrkB expression was significantly lower in BTBR mice compared to WT (Figure [2E](#F2){ref-type="fig"}). No significant differences in Akt1 expression was noted in the BTBR model compared to WT (Figure [2F](#F2){ref-type="fig"}). Levels of phosphorylated synapsin 1 (Figure [2G](#F2){ref-type="fig"}), but not total synapsin 1 (Figure [2H](#F2){ref-type="fig"}) were significantly elevated in BTBR mice compared to WT. Expression of both synaptophysin (Figure [2I](#F2){ref-type="fig"}) and PSD95 (Figure [2J](#F2){ref-type="fig"}) was not affected in BTBR mice, while both spinophilin (Figure [2K](#F2){ref-type="fig"}) and NeuN (Figure [2L](#F2){ref-type="fig"}) levels were significantly elevated in BTBR mice compared to WT.

In the hippocampus we again found no significant differences in the levels of pro-BDNF between BTBR and WT (Figure [3B](#F3){ref-type="fig"}) that was coincident with a significant reduction in extant BDNF levels (Figure [3C](#F3){ref-type="fig"}). Phosphorylated TrkB expression was unchanged in BTBR mice compared to WT (Figure [3D](#F3){ref-type="fig"}), while there was a trend, similar to that in the cortex, to reductions of total TrkB receptor expression in the BTBR mice (Figure [3E](#F3){ref-type="fig"}). As with the cortex no significant alterations in Akt1 were observed (Figure [3F](#F3){ref-type="fig"}). Significant potentiation of both phosphorylated (Figure [3G](#F3){ref-type="fig"}) and non-phosphorylated synapsin 1 (Figure [3H](#F3){ref-type="fig"}) expression levels was seen in the BTBR hippocampus. In accordance with the cortical data we found no significant BTBR-induced changes in the hippocampal expression of synaptophysin (Figure [3I](#F3){ref-type="fig"}) or PSD95 (Figure [3J](#F3){ref-type="fig"}). Levels of both spinophilin (Figure [3K](#F3){ref-type="fig"}) and NeuN (Figure [3L](#F3){ref-type="fig"}) were again significantly potentiated in the BTBR mice, mirroring our previous cortical data.

![**Protein expression in wild type and BTBR mouse hippocampus**. Western blotting was performed using mouse hippocampal protein lysates **(A)**. Protein levels were measured in BTBR and control mice with respect to the following proteins in the hippocampus: pro-BDNF **(B)**, mature BDNF **(C)**, phospho-TrkB **(D)**, total TrkB **(E)**, Akt **(F)** phospho-synapsin 1 **(G)**, synapsin 1 **(H)** synaptophysin **(I)**, PSD95 **(J)**, spinophilin **(K)**, Neuronal cell marker NeuN **(L)**. Data are expressed as means ± s.e.m. Asterisks represent *p*-values as shown: ^\*^*p* \< 0.05, ^\*\*^*p* \< 0.01. Statistical significance was measured using a Student\'s *t*-test, *n* = 3 for each group.](fnagi-06-00225-g0003){#F3}

Systemic analysis of BTBR central nervous protein expression
------------------------------------------------------------

To gain an unbiased appreciation of the multiple tissue protein expression pattern changes generated in the BTBR mice compare to WT we applied quantitative isobaric mass-tag labeling (iTRAQ) to cortical and hippocampal tissue extracts. In the cortex we identified and generated relative expression profiles for 674 proteins (Figure [4A](#F4){ref-type="fig"}: Table [S1](#SM3){ref-type="supplementary-material"}), while in the hippocampus 656 proteins were identified and quantified in BTBR mice (Figure [4B](#F4){ref-type="fig"}: Table [S2](#SM4){ref-type="supplementary-material"}). Log~2~-transformed iTRAQ expression ratios were employed to generate snake plot graphs of individual proteins. To initially validate some of the iTRAQ data we chose three random proteins, Rab3A, CaMKIID and Cplx1 and found that at the western level of detection our results were comparable to our iTRAQ expression ratio data (Figures [4C,D](#F4){ref-type="fig"}).

![**Quantitative proteomic and bioinformatics analysis of BTBR CNS tissues**. Log~2~transformed iTRAQ ratio data (BTBR:WT) snake plot of the proteins identified in the cortex **(A)** and hippocampus **(B)** are depicted. Upregulated proteins are highlighted in red, while downregulated proteins are highlighted in green. Three proteins identified by iTRAQ were validated via western blot and results correlated to the iTRAQ results **(C, D)**. Data are expressed as means ± s.e.m. Asterisks represent *p*-values as shown: ^\*^*p* \< 0.05. Statistical significance was measured using a Student\'s *t*-test.](fnagi-06-00225-g0004){#F4}

Gene ontology bioinformatic analysis of BTBR-specific altered proteins
----------------------------------------------------------------------

Using a standard arbitrary cut-off of \>1.2 (elevated in BTBR vs. WT) or \<0.8 (reduced in BTBR vs. WT) for the iTRAQ ratios for differentially expressed proteins between BTBR and WT mice we investigated the functional clustering of the BTBR-specific protein changes into Gene Ontology term groups. Analysis of the differentially--regulated \[elevated (\<1.2) and reduced (\<0.8)\] proteins in the BTBR cortex we found a strong GO-biological process clustering of endoplasmic reticular, vesicular transport and neurotransmission related functions (Table [1](#T1){ref-type="table"}). No GO-molecular function annotation was achieved with the cortical data however. With respect to GO-cellular compartment analysis we found the differential BTBR proteins were strongly associated with endocytic activity, neuronal outgrowth and architecture as well as mitochondrial metabolic activity (Table [1](#T1){ref-type="table"}). GO-biological process analysis of the differential BTBR hippocampal protein set indicated a strong bias toward neuronal synaptic secretion, neuronal plasticity, metabolic activity and inter-cellular contact (Table [2](#T2){ref-type="table"}). GO-cellular compartment interrogation of the hippocampal dataset revealed a strong bias for protein interactions in the synaptic cleft, clathrin-coated vesicles and mitochondrial-associated metabolic areas (Table [2](#T2){ref-type="table"}). GO-molecular function annotation was evident with the hippocampal data and revealed the presence of GO groups associated with malate metabolism, redox activity, synaptic vesicle docking and structural modeling (Table [2](#T2){ref-type="table"}).

###### 

**GO term analysis for cortical protein alterations observed in aged BTBR compared to WT control**.

  **GO group**         **GO term**                                          **GO ID**   ***C***   ***O***   ***E***   ***R***   ***P***    ***H***
  -------------------- ---------------------------------------------------- ----------- --------- --------- --------- --------- ---------- ----------
  Biological process   Endoplasmic reticulum tubular network organization   71786       4         2         0.02      126.12    0.0047     293.595
  Biological process   Early endosome to late endosome transport            45022       21        3         0.08      36.03     0.0041     86.0114
  Biological process   Vesicle-mediated transport                           16192       909       14        3.6       3.88      0.0018     10.64954
  Biological process   Secretion by cell                                    32940       693       11        2.75      4         0.0041     9.548865
  Biological process   Secretion                                            46903       795       12        3.15      3.81      0.0037     9.265151
  Biological process   Transmission of nerve impulse                        19226       735       11        2.91      3.78      0.0047     8.79947
  Biological process   Neurological system process                          50877       1237      16        4.9       3.26      0.002      8.798642
  Biological process   System process                                       3008        1695      19        6.72      2.83      0.002      7.638085
  Biological process   Multicellular organismal signaling                   35637       751       11        2.98      3.69      0.0087     7.603174
  Biological process   Transport                                            6810        3338      30        13.23     2.27      0.0006     7.313597
  Biological process   Establishment of localization                        51234       3392      30        13.45     2.23      0.0006     7.184723
  Biological process   Establishment of localization in cell                51649       1756      19        6.96      2.73      0.0027     7.012377
  Biological process   Cellular localization                                51641       1977      20        7.84      2.55      0.0035     6.262626
  Biological process   Localization                                         51179       4167      31        16.52     1.88      0.0037     4.571781
  Cellular component   Chaperonin-containing T-complex                      5832        7         2         0.03      78.59     0.0039     189.3182
  Cellular component   Pericentriolar material                              242         12        2         0.04      45.84     0.0076     97.1435
  Cellular component   Clathrin-sculpted vesicle                            60198       12        2         0.04      45.84     0.0076     97.1435
  Cellular component   Clathrin-coated vesicle membrane                     30665       110       5         0.4       12.5      0.0011     36.98259
  Cellular component   Filopodium                                           30175       55        3         0.2       15        0.0076     31.7878
  Cellular component   Coated pit                                           5905        57        3         0.21      14.48     0.0082     30.20798
  Cellular component   Coated vesicle membrane                              30662       150       5         0.55      9.17      0.0032     22.87777
  Cellular component   Lamellipodium                                        30027       121       4         0.44      9.09      0.0076     19.2634
  Cellular component   Ruffle                                               1726        123       4         0.45      8.94      0.0076     18.94553
  Cellular component   Neuron projection                                    43005       651       12        2.37      5.07      0.0002     18.75378
  Cellular component   Cell leading edge                                    31252       257       6         0.93      6.42      0.0039     15.46537
  Cellular component   Clathrin-coated vesicle                              30136       207       5         0.75      6.64      0.0076     14.0714
  Cellular component   Cell projection                                      42995       1230      16        4.47      3.58      0.0002     13.24231
  Cellular component   Mitochondrion                                        5739        1525      18        5.54      3.25      0.0002     12.02165
  Cellular component   Cytoplasmic part                                     44444       6772      44        24.62     1.79      7.70E-05   7.363182
  Cellular component   Microtubule cytoskeleton                             15630       863       10        3.14      3.19      0.0076     6.760205
  Cellular component   Cytoskeleton                                         5856        1790      15        6.51      2.3       0.0093     4.672489
  Cellular component   Cytoplasm                                            5737        9130      49        33.19     1.48      0.0007     4.669255
  Cellular component   Cytosol                                              5829        2372      18        8.62      2.09      0.0093     4.245871
  Cellular component   Intracellular                                        5622        12564     58        45.68     1.27      0.0012     3.70944
  Cellular component   Intracellular part                                   44424       12237     55        44.49     1.24      0.0082     2.586871

*GO term annotation of the cortical proteins possessing BTBR:WT iTRAQ expression ratios \<1.2 or \<0.8 were created using WebGestalt. Each GO term group significantly populated (p \< 0.05) by at least two independent proteins are depicted. For each GO Term group the specific GO term ID, number of total proteins in the curated GO term cluster (C), the number of observed experimental proteins in the GO term group (O), the expected number of proteins in the group based on whole-genome background frequency (E), the GO term group enrichment factor (R), the GO term enrichment probability (P) and the hybrid score (R ^\*^ −log~10~ P) are indicated (H)*.

###### 

**GO term analysis for hippocampal protein alterations observed in aged BTBR compared to WT controls**.

  **GO Class**         **GO Term**                                                                                 **GO ID**   ***C***   ***E***   ***O***   ***R***   ***P***     ***H***
  -------------------- ------------------------------------------------------------------------------------------- ----------- --------- --------- --------- --------- ----------- ----------
  Biological process   Neurotransmitter secretion                                                                  7269        99        15        1.25      11.98     4.40E--10   112.0914
  Biological process   Synaptic vesicle endocytosis                                                                48488       22        6         0.28      21.57     8.46E--06   109.4166
  Biological process   Regulation of neuronal synaptic plasticity                                                  48168       47        9         0.59      15.14     4.14E--07   96.63861
  Biological process   Synaptic vesicle transport                                                                  48489       68        11        0.86      12.79     5.71E--08   92.64262
  Biological process   Regulation of synaptic plasticity                                                           48167       96        13        1.21      10.71     1.68E--08   83.26694
  Biological process   Neurotransmitter transport                                                                  6836        133       15        1.68      8.92      1.21E--08   70.62155
  Biological process   Synaptic transmission                                                                       7268        651       41        8.23      4.98      8.14E--15   70.16509
  Biological process   Regulation of neurotransmitter levels                                                       1505        137       15        1.73      8.66      1.54E--08   67.65607
  Biological process   Regulation of synaptic transmission                                                         50804       186       18        2.35      7.65      3.76E--09   64.44981
  Biological process   Regulation of neurological system process                                                   31644       217       19        2.74      6.92      5.27E--09   57.28507
  Biological process   Regulation of transmission of nerve impulse                                                 51969       204       18        2.58      6.98      1.08E--08   55.6067
  Biological process   Transmission of nerve impulse                                                               19226       735       41        9.29      4.41      2.94E--13   55.26459
  Biological process   Multicellular organismal signaling                                                          35637       751       41        9.5       4.32      4.13E--13   53.4991
  Biological process   Respiratory electron transport chain                                                        22904       110       12        1.39      8.63      8.22E--07   52.51466
  Biological process   Signal release                                                                              23061       344       23        4.35      5.29      8.37E--09   42.72878
  Biological process   Generation of a signal involved in cell-cell signaling                                      3001        344       23        4.35      5.29      8.37E--09   42.72878
  Biological process   Cellular respiration                                                                        45333       159       14        2.01      6.96      8.22E--07   42.35249
  Biological process   Energy derivation by oxidation of organic compounds                                         15980       329       22        4.16      5.29      1.54E--08   41.32802
  Biological process   Cell-cell signaling                                                                         7267        1099      48        13.9      3.45      3.98E--12   39.3304
  Biological process   Generation of precursor metabolites and energy                                              6091        451       26        5.7       4.56      1.07E--08   36.34601
  Biological process   Neurological system process                                                                 50877       1237      44        15.64     2.81      1.54E--08   21.95307
  Biological process   Small molecule metabolic process                                                            44281       2515      71        31.8      2.23      1.02E--09   20.05082
  Biological process   Cell morphogenesis involved in neuron differentiation                                       48667       575       25        7.27      3.44      3.07E--06   18.96424
  Biological process   Regulation of biological quality                                                            65008       2511      70        31.75     2.2       2.49E--09   18.92836
  Biological process   Neuron projection morphogenesis                                                             48812       583       25        7.37      3.39      3.70E--06   18.4138
  Biological process   Neuron development                                                                          48666       798       31        10.09     3.07      1.11E--06   18.28086
  Biological process   Regulation of system process                                                                44057       455       21        5.75      3.65      1.05E--05   18.17266
  Biological process   Secretion by cell                                                                           32940       693       28        8.76      3.2       2.39E--06   17.98913
  Biological process   Axonogenesis                                                                                7409        526       23        6.65      3.46      7.81E--06   17.67143
  Biological process   Neuron projection development                                                               31175       704       28        8.9       3.15      3.07E--06   17.36551
  Biological process   Secretion                                                                                   46903       795       30        10.05     2.98      3.07E--06   16.42833
  Biological process   Neuron differentiation                                                                      30182       990       34        12.52     2.72      3.46E--06   14.85371
  Biological process   Nervous system development                                                                  7399        1724      50        21.8      2.29      6.25E--07   14.20743
  Biological process   Establishment of localization in cell                                                       51649       1756      50        22.21     2.25      1.01E--06   13.49028
  Biological process   Generation of neurons                                                                       48699       1073      35        13.57     2.58      6.71E--06   13.34706
  Biological process   Cellular localization                                                                       51641       1977      53        25        2.12      2.31E--06   11.94914
  Biological process   Establishment of localization                                                               51234       3392      74        42.89     1.73      7.81E--06   8.835714
  Biological process   Transport                                                                                   6810        3338      73        42.21     1.73      8.58E--06   8.765067
  Biological process   SinglE--multicellular organism process                                                      44707       5612      106       70.97     1.49      4.87E--06   7.915582
  Biological process   Multicellular organismal process                                                            32501       5644      106       71.37     1.49      6.63E--06   7.715945
  Molecular function   Malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity                        4473        2         2         0.02      81.3      0.0023      214.4915
  Molecular function   Malate dehydrogenase (oxaloacetate-decarboxylating) activity                                16619       3         2         0.04      54.2      0.0039      130.5643
  Molecular function   Thioredoxin peroxidase activity                                                             8379        3         2         0.04      54.2      0.0039      130.5643
  Molecular function   Malic enzyme activity                                                                       4470        4         2         0.05      40.65     0.0063      89.45681
  Molecular function   Hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides     16812       10        3         0.12      24.39     0.0023      64.34746
  Molecular function   NAD binding                                                                                 51287       49        7         0.6       11.61     0.0001      46.44
  Molecular function   Calmodulin-dependent protein kinase activity                                                4683        21        4         0.26      15.49     0.0017      42.90035
  Molecular function   Proline-rich region binding                                                                 70064       15        3         0.18      16.26     0.0062      35.89571
  Molecular function   Syntaxin binding                                                                            19905       38        5         0.47      10.7      0.0017      29.6342
  Molecular function   NADH dehydrogenase (ubiquinone) activity                                                    8137        44        5         0.54      9.24      0.0023      24.37763
  Molecular function   NADH dehydrogenase (quinone) activity                                                       50136       44        5         0.54      9.24      0.0023      24.37763
  Molecular function   NADH dehydrogenase activity                                                                 3954        44        5         0.54      9.24      0.0023      24.37763
  Molecular function   SNARE binding                                                                               149         45        5         0.55      9.03      0.0023      23.8236
  Molecular function   Cofactor binding                                                                            48037       262       15        3.22      4.65      7.65E--05   19.14097
  Molecular function   Actin filament binding                                                                      51015       72        6         0.89      6.77      0.0033      16.79966
  Molecular function   Coenzyme binding                                                                            50662       186       11        2.29      4.81      0.0005      15.87795
  Molecular function   Oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor   16655       58        5         0.71      7.01      0.0062      15.47533
  Molecular function   Calmodulin binding                                                                          5516        164       10        2.02      4.96      0.0008      15.36067
  Molecular function   Hydrogen ion transmembrane transporter activity                                             15078       101       7         1.24      5.63      0.0023      14.85347
  Molecular function   Cytoskeletal protein binding                                                                8092        638       25        7.85      3.19      3.90E--05   14.0645
  Molecular function   Oxidoreductase activity                                                                     16491       711       24        8.75      2.74      0.0003      9.652688
  Molecular function   Actin binding                                                                               3779        356       14        4.38      3.2       0.0017      8.862563
  Molecular function   GTPase activity                                                                             3924        231       10        2.84      3.52      0.0057      7.899321
  Molecular function   Identical protein binding                                                                   42802       863       25        10.62     2.36      0.0012      6.893132
  Molecular function   Anion binding                                                                               43168       2402      54        29.55     1.83      0.0002      6.769115
  Molecular function   Small molecule binding                                                                      36094       2630      58        32.35     1.79      0.0002      6.621156
  Molecular function   Protein binding                                                                             5515        7337      126       90.25     1.4       2.47E--05   6.450224
  Molecular function   Nucleoside phosphate binding                                                                1901265     2437      53        29.98     1.77      0.0005      5.842823
  Molecular function   Nucleotide binding                                                                          166         2436      52        29.96     1.74      0.0007      5.489529
  Molecular function   Nucleoside-triphosphatase activity                                                          17111       760       21        9.35      2.25      0.0039      5.420105
  Molecular function   Pyrophosphatase activity                                                                    16462       794       21        9.77      2.15      0.0063      4.731418
  Molecular function   Hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides          16818       797       21        9.8       2.14      0.0063      4.709411
  Molecular function   Catalytic activity                                                                          3824        5371      94        66.07     1.42      0.0005      4.687463
  Molecular function   Hydrolase activity, acting on acid anhydrides                                               16817       802       21        9.86      2.13      0.0063      4.687405
  Molecular function   Purine ribonucleoside triphosphate binding                                                  35639       1829      38        22.5      1.69      0.0063      3.719114
  Molecular function   Purine nucleoside binding                                                                   1883        1841      38        22.65     1.68      0.0063      3.697108
  Molecular function   Purine ribonucleoside binding                                                               32550       1838      38        22.61     1.68      0.0063      3.697108
  Molecular function   Ribonucleoside binding                                                                      32549       1842      38        22.66     1.68      0.0063      3.697108
  Molecular function   Nucleoside binding                                                                          1882        1852      38        22.78     1.67      0.0068      3.61971
  Molecular function   Purine ribonucleotide binding                                                               32555       1864      38        22.93     1.66      0.0073      3.546884
  Cellular component   Synapse                                                                                     45202       489       28        5.45      5.14      3.35E--11   53.84127
  Cellular component   Mitochondrial respiratory chain                                                             5746        69        8         0.77      10.41     6.79E--06   53.80024
  Cellular component   Neuron projection                                                                           43005       651       33        7.25      4.55      1.02E--11   50.01087
  Cellular component   Synaptic vesicle                                                                            8021        105       10        1.17      8.55      2.14E--06   48.47496
  Cellular component   Axon                                                                                        30424       286       19        3.19      5.96      8.47E--09   48.10981
  cellular component   Respiratory chain                                                                           70469       76        8         0.85      9.45      1.32E--05   46.11058
  Cellular component   Clathrin-coated vesicle membrane                                                            30665       110       10        1.23      8.16      3.21E--06   44.82692
  Cellular component   Vesicle membrane                                                                            12506       355       21        3.96      5.31      8.47E--09   42.86294
  Cellular component   Cytoplasmic vesicle membrane                                                                30659       342       20        3.81      5.25      2.52E--08   39.89265
  Cellular component   Cytoplasm                                                                                   5737        9130      170       101.72    1.67      1.52E--24   39.77632
  Cellular component   Cytoplasmic part                                                                            44444       6772      143       75.45     1.9       1.86E--21   39.38793
  Cellular component   Clathrin-coated vesicle                                                                     30136       207       14        2.31      6.07      7.60E--07   37.14346
  Cellular component   Cell projection                                                                             42995       1230      45        13.7      3.28      2.51E--11   34.76907
  Cellular component   Coated vesicle membrane                                                                     30662       150       11        1.67      6.58      6.79E--06   34.0063
  Cellular component   Cytoplasmic vesicle part                                                                    44433       401       21        4.47      4.7       6.16E--08   33.88897
  Cellular component   Cytosol                                                                                     5829        2372      69        26.43     2.61      4.11E--13   32.32787
  Cellular component   Coated vesicle                                                                              30135       254       15        2.83      5.3       1.44E--06   30.96068
  Cellular component   Mitochondrion                                                                               5739        1525      48        16.99     2.83      5.17E--10   26.28082
  Cellular component   Synapse part                                                                                44456       370       18        4.12      4.37      1.46E--06   25.50178
  Cellular component   Membrane-bounded vesicle                                                                    31988       883       32        9.84      3.25      4.82E--08   23.7801
  Cellular component   Mitochondrial inner membrane                                                                5743        354       17        3.94      4.31      3.58E--06   23.47276
  Cellular component   Cytoplasmic membrane-bounded vesicle                                                        16023       862       31        9.6       3.23      8.13E--08   22.90041
  Cellular component   Mitochondrial part                                                                          44429       744       27        8.29      3.26      5.82E--07   20.32635
  Cellular component   Organelle inner membrane                                                                    19866       384       17        4.28      3.97      1.01E--05   19.83284
  Cellular component   Vesicle                                                                                     31982       970       32        10.81     2.96      3.20E--07   19.22476
  Cellular component   Cytoplasmic vesicle                                                                         31410       928       31        10.34     3         3.93E--07   19.21682
  Cellular component   Intracellular part                                                                          44424       12237     179       136.34    1.31      2.42E--13   16.5272
  Cellular component   Intracellular                                                                               5622        12564     180       139.98    1.29      1.32E--12   15.32446
  Cellular component   Organelle membrane                                                                          31090       2373      57        26.44     2.16      8.13E--08   15.3142
  Cellular component   Intracellular organelle part                                                                44446       6725      120       74.93     1.6       5.80E--10   14.77852
  Cellular component   Organelle part                                                                              44422       6812      120       75.9      1.58      1.42E--09   13.97938
  Cellular component   Cytoskeleton                                                                                5856        1790      45        19.94     2.26      1.06E--06   13.50281
  Cellular component   Protein complex                                                                             43234       3278      70        36.52     1.92      9.89E--08   13.44922
  Cellular component   Cell part                                                                                   44464       14643     189       163.15    1.16      1.90E--10   11.27665
  Cellular component   Cell                                                                                        5623        14644     189       163.16    1.16      1.90E--10   11.27665
  Cellular component   Macromolecular complex                                                                      32991       3864      76        43.05     1.77      5.44E--07   11.08799
  Cellular component   Intracellular organelle                                                                     43229       10636     155       118.5     1.31      8.09E--08   9.290587
  Cellular component   Organelle                                                                                   43226       10651     155       118.67    1.31      8.13E--08   9.287781
  Cellular component   Intracellular membrane-bounded organelle                                                    43231       9587      138       106.82    1.29      1.32E--05   6.29446
  Cellular component   Membrane-bounded organelle                                                                  43227       9598      138       106.94    1.29      1.36E--05   6.277735

*GO term annotation of the cortical proteins possessing BTBR:WT iTRAQ expression ratios \<1.2 or \<0.8 were created using WebGestalt. Each GO term group significantly populated (p\<0.05) by at least two independent proteins are depicted. For each GO Term group the specific GO term ID, number of total proteins in the curated GO term cluster (C), the number of observed experimental proteins in the GO term group (O), the expected number of proteins in the group based on whole-genome background frequency (E), the GO term group enrichment factor (R), the GO term enrichment probability (P) and the hybrid score (R ^\*^ −log~10~ P) are indicated (H)*.

Signaling pathway analysis of differentially regulated BTBR-specific proteins
-----------------------------------------------------------------------------

While GO annotation indicates some degree of functional commonality between groups of proteins, associating multiple proteins with classically-identified molecular signaling paradigms provides additional functional information regarding the potential physiological ramifications of specific group of differentially-regulated factors. We therefore performed both KEGG and Ingenuity-base pathway analysis upon our cortical and hippocampal BTBR protein sets. Inspecting the top ten highest scoring KEGG pathways from cortical proteins (Figure [5A](#F5){ref-type="fig"}: Table [3](#T3){ref-type="table"}) a strong population of metabolic (*Glutathione metabolism*, *Insulin signaling pathway*, *Metabolic pathways*), neurotransmission/degenerative (*Neurotrophic signaling pathway*, *Alzheimer\'s disease*) and ultrastructural (*Gap junction*, *Tight junction*, *Spliceosome*) signaling pathways was evident. Applying the same analysis to the hippocampus an intense population of signaling systems linked to oxidative metabolism \[*Oxidative phosphorylation*, *Pyruvate metabolism*, *Citrate cycle (TCA cycle)*\] and central neurodegeneration (*Alzheimer\'s disease*, *Huntington\'s disease*, *Parkinson\'s disease*, *Long-term potentiation*) was clear (Figure [5B](#F5){ref-type="fig"}: Table [4](#T4){ref-type="table"}). Extraction of potential physiological meaning from complex data sets is best performed using multiple informatics tools. Therefore, we also sought interpretation of the potential signaling pathways enriched in the BTBR tissues using canonical signaling pathway analysis (Ingenuity). Canonical signaling analysis of the cortex revealed a strong bias toward cytokine signaling (*Leptin signaling in obesity*, *JAK family kinases in IL-6-type signaling*), neurodegenerative disease related activity (*Amyloid processing*, *CDK5 signaling*, *CNTF signaling*) and energy metabolism (IGF-1 signaling) (Figure [5C](#F5){ref-type="fig"}: Table [5](#T5){ref-type="table"}). Similar pathway processing of hippocampal data again revealed a strong prediction of metabolism-related activity (*Oxidative phosphorylation*, *Mitochondrial dysfunction*, *G protein signaling mediated by Tubby*), neurodegenerative activity (*Huntington\'s disease signaling*) and interestingly, given the strong presentation of, *Melanocyte development and pigmentation signaling\'* in the cortex (Figure [5C](#F5){ref-type="fig"}), melatonin-related activity (*Melatonin signaling*) (Figure [5D](#F5){ref-type="fig"}: Table [6](#T6){ref-type="table"}).

![**Signaling pathway analysis of cortical and hippocampal proteins differentially regulated BTBR and WT**. Cortical and hippocampal proteins exhibiting differential regulation between BTBR and control mice were analyzed for potential functional pathway interactions using KEGG (**A**-cortex, **B**-hippocampus) and Ingenuity Canonical Signaling pathway analysis (**C**-cortex, **D**-hippocampus). For **(A,B)**, the top 10 most significantly-populated (calculated with Hybrid scores: enrichment factor (R) ^\*^ (−log~10~ enrichment probability, P) neuronally-specific KEGG or Canonical signaling pathways are shown.](fnagi-06-00225-g0005){#F5}

###### 

**KEGG Pathway analysis for cortical proteins altered in BTBR mice compared to WT controls**.

  **KEGG pathway**                            ***C***   ***E***   ***O***   ***R***   ***P***   ***H***
  ------------------------------------------- --------- --------- --------- --------- --------- ----------
  Glutathione metabolism                      50        2         0.07      27.38     0.0188    47.25356
  MTOR signaling pathway                      52        2         0.08      26.33     0.0188    45.44142
  Arginine and proline metabolism             54        2         0.08      25.35     0.0188    43.7501
  Shigellosis                                 61        2         0.09      22.44     0.0188    38.7279
  Renal cell carcinoma                        70        2         0.1       19.56     0.0188    33.75747
  Chronic myeloid leukemia                    73        2         0.11      18.75     0.0188    32.35954
  Progesterone-mediated oocyte maturation     86        2         0.13      15.92     0.0188    27.47541
  Gap junction                                90        2         0.13      15.21     0.0188    26.25006
  Melanogenesis                               101       2         0.15      13.56     0.0192    23.27844
  GnRH signaling pathway                      101       2         0.15      13.56     0.0192    23.27844
  Oocyte meiosis                              112       2         0.16      12.22     0.0192    20.97806
  Leukocyte transendothelial migration        116       2         0.17      11.8      0.0192    20.25705
  Vascular smooth muscle contraction          116       2         0.17      11.8      0.0192    20.25705
  Neurotrophin signaling pathway              127       2         0.19      10.78     0.0192    18.50601
  Spliceosome                                 127       2         0.19      10.78     0.0192    18.50601
  Tight junction                              132       2         0.19      10.37     0.0192    17.80217
  Hepatitis C                                 134       2         0.2       10.22     0.0192    17.54466
  Natural killer cell mediated cytotoxicity   136       2         0.2       10.07     0.0192    17.28716
  Insulin signaling pathway                   138       2         0.2       9.92      0.0192    17.02965
  Alzheimer\'s disease                        167       2         0.24      8.2       0.0261    12.98355
  Chemokine signaling pathway                 189       2         0.28      7.24      0.0313    10.89226
  Metabolic pathways                          1130      6         1.65      3.63      0.0188    6.264807

*KEGG signaling pathway annotation of the cortical proteins possessing BTBR:WT iTRAQ expression ratios \< 1.2 or \< 0.8 was created using WebGestalt. Each KEGG pathway significantly populated (p \< 0.05) by at least two independent proteins are depicted. For each populated KEGG pathway the number of total proteins in the curated KEGG pathway (C), the number of observed experimental proteins in the KEGG pathway (O), the expected number of proteins in the pathway based on whole-genome background frequency (E), the KEGG pathway enrichment factor (R), the KEGG pathway enrichment probability (P) and the hybrid score (R ^\*^ −log~10~ P) are indicated (H)*.

###### 

**KEGG Pathway analysis for hippocampal proteins altered in BTBR mice compared to WT controls**.

  **KEGG pathway**                                             ***C***   ***E***   ***O***   ***R***   ***P***     ***H***
  ------------------------------------------------------------ --------- --------- --------- --------- ----------- ----------
  Oxidative phosphorylation                                    132       15        0.61      24.63     1.42E--15   365.6991
  Alzheimer\'s disease                                         167       17        0.77      22.06     1.03E--16   352.6768
  Huntington\'s disease                                        183       18        0.84      21.32     2.92E--17   352.518
  Parkinson\'s disease                                         130       12        0.6       20        1.88E--11   214.5168
  Long--term potentiation                                      70        8         0.32      24.77     1.74E--08   192.2016
  Gastric acid secretion                                       74        8         0.34      23.43     2.34E--08   178.7893
  Collecting duct acid secretion                               27        4         0.12      32.11     4.01E--05   141.183
  Pyruvate metabolism                                          40        5         0.18      27.09     7.57E--06   138.7253
  Metabolic pathways                                           1130      37        5.21      7.1       5.38E--19   129.7114
  GnRH signaling pathway                                       101       8         0.47      17.17     2.19E--07   114.3446
  Oocyte meiosis                                               112       8         0.52      15.48     4.04E--07   98.97322
  Calcium signaling pathway                                    177       10        0.82      12.24     1.14E--07   84.98348
  Vasopressin-regulated water reabsorption                     44        4         0.2       19.7      0.0002      72.86971
  Endocytosis                                                  201       10        0.93      10.78     3.03E--07   70.27005
  Citrate cycle (TCA cycle)                                    30        3         0.14      21.67     0.001       65.01
  Butanoate metabolism                                         30        3         0.14      21.67     0.001       65.01
  Propanoate metabolism                                        32        3         0.15      20.32     0.001       60.96
  Alanine, aspartate and glutamate metabolism                  32        3         0.15      20.32     0.001       60.96
  Melanogenesis                                                101       6         0.47      12.87     4.15E--05   56.39572
  Vibrio cholerae infection                                    54        4         0.25      16.05     0.0004      54.53694
  Shigellosis                                                  61        4         0.28      14.21     0.0007      44.83116
  Wnt signaling pathway                                        150       7         0.69      10.11     4.01E--05   44.45221
  Salivary secretion                                           89        5         0.41      12.18     0.0003      42.90866
  Gap junction                                                 90        5         0.42      12.04     0.0003      42.41546
  Beta-Alanine metabolism                                      22        2         0.1       19.7      0.0071      42.33021
  Glioma                                                       65        4         0.3       13.34     0.0007      42.08639
  Neurotrophin signaling pathway                               127       6         0.59      10.24     0.0001      40.96
  Valine, leucine and isoleucine degradation                   44        3         0.2       14.78     0.0023      38.99366
  Proteasome                                                   44        3         0.2       14.78     0.0023      38.99366
  Epithelial cell signaling in Helicobacter pylori infection   68        4         0.31      12.75     0.0009      38.83341
  PPAR signaling pathway                                       70        4         0.32      12.38     0.0009      37.70648
  Long-term depression                                         70        4         0.32      12.38     0.0009      37.70648
  Bile secretion                                               71        4         0.33      12.21     0.0009      37.1887
  Cardiac muscle contraction                                   77        4         0.36      11.26     0.0012      32.88842
  Phosphatidylinositol signaling system                        78        4         0.36      11.11     0.0012      32.4503
  Pentose phosphate pathway                                    27        2         0.12      16.05     0.0103      31.89396
  Amyotrophic lateral sclerosis (ALS)                          53        3         0.24      12.27     0.0036      29.98417
  ErbB signaling pathway                                       87        4         0.4       9.96      0.0016      27.84696
  Inositol phosphate metabolism                                57        3         0.26      11.41     0.0043      27.00212
  Regulation of actin cytoskeleton                             213       7         0.98      7.12      0.0003      25.0829
  Glycolysis/Gluconeogenesis                                   65        3         0.3       10        0.0057      22.44125
  Prion diseases                                               35        2         0.16      12.38     0.0158      22.30063
  African trypanosomiasis                                      35        2         0.16      12.38     0.0158      22.30063
  Pancreatic secretion                                         101       4         0.47      8.58      0.0026      22.17953
  Adipocytokine signaling pathway                              68        3         0.31      9.56      0.0064      20.97292
  Bacterial invasion of epithelial cells                       70        3         0.32      9.29      0.0066      20.25644
  Renal cell carcinoma                                         70        3         0.32      9.29      0.0066      20.25644
  Vascular smooth muscle contraction                           116       4         0.54      7.47      0.0039      17.99475
  Antigen processing and presentation                          76        3         0.35      8.55      0.0081      17.88245
  Purine metabolism                                            162       5         0.75      6.69      0.0023      17.65004
  Protein processing in endoplasmic reticulum                  165       5         0.76      6.57      0.0023      17.33345
  Lysosome                                                     121       4         0.56      7.16      0.0044      16.87288
  Spliceosome                                                  127       4         0.59      6.83      0.005       15.71603
  Chemokine signaling pathway                                  189       5         0.87      5.73      0.0036      14.00239
  Rheumatoid arthritis                                         91        3         0.42      7.14      0.0127      13.53884
  Fc gamma R-mediated phagocytosis                             94        3         0.43      6.92      0.0136      12.91591
  Taste transduction                                           52        2         0.24      8.34      0.0313      12.54716
  MAPK signaling pathway                                       268       6         1.24      4.85      0.0032      12.10002
  Arginine and proline metabolism                              54        2         0.25      8.03      0.0325      11.94958
  Pathogenic Escherichia coli infection                        56        2         0.26      7.74      0.0342      11.34664
  Chagas disease (American trypanosomiasis)                    104       3         0.48      6.25      0.017       11.05969
  Amoebiasis                                                   106       3         0.49      6.13      0.0177      10.73992
  Toxoplasmosis                                                132       3         0.61      4.93      0.0309      7.444505
  Natural killer cell mediated cytotoxicity                    136       3         0.63      4.78      0.0324      7.119595
  Phagosome                                                    153       3         0.71      4.25      0.0416      5.868853

*KEGG signaling pathway annotation of the hippocampal proteins possessing BTBR:WT iTRAQ expression ratios \< 1.2 or \< 0.8 was created using WebGestalt. Each KEGG pathway significantly populated (p \< 0.05) by at least two independent proteins are depicted. For each populated KEGG pathway the number of total proteins in the curated KEGG pathway (C), the number of observed experimental proteins in the KEGG pathway (O), the expected number of proteins in the pathway based on whole-genome background frequency (E), the KEGG pathway enrichment factor (R), the KEGG pathway enrichment probability (P) and the hybrid score (R ^\*^ −log~10~ P) are indicated (H)*.

###### 

**Ingenuity Canonical Signaling Pathway analysis of proteins differentially regulated in the cortex of aged BTBR compared to WT controls**.

  **Canonical pathways**                                       **log(*p*-value)**   **Ratio**   **10 × Hybrid**
  ------------------------------------------------------------ -------------------- ----------- -----------------
  Leptin Signaling in Obesity                                  3.97E + 00           4.71E--02   1.86987
  Role of JAK family kinases in IL-6-type Cytokine Signaling   2.52E + 00           7.14E--02   1.79928
  Amyloid Processing                                           3.20E + 00           4.92E--02   1.5744
  Melanocyte Development and Pigmentation Signaling            3.73E + 00           4.21E--02   1.57033
  Gαi Signaling                                                3.16E + 00           2.96E--02   0.93536
  Dopamine Receptor Signaling                                  2.70E + 00           3.12E--02   0.8424
  CDK5 Signaling                                               2.52E + 00           3.09E--02   0.77868
  α-Adrenergic Signaling                                       2.52E + 00           2.75E--02   0.693
  IGF-1 Signaling                                              2.40E + 00           2.80E--02   0.672
  CNTF Signaling                                               1.90E + 00           3.51E--02   0.6669
  Neuropathic Pain Signaling In Dorsal Horn Neurons            2.36E + 00           2.75E--02   0.649
  G Beta Gamma Signaling                                       2.50E + 00           2.48E--02   0.62
  IL-2 Signaling                                               1.88E + 00           3.28E--02   0.61664
  Thrombopoietin Signaling                                     1.85E + 00           3.12E--02   0.5772
  Renin-Angiotensin Signaling                                  2.26E + 00           2.38E--02   0.53788
  Gαs Signaling                                                2.22E + 00           2.40E--02   0.5328
  Role of JAK1 and JAK3 in γc Cytokine Signaling               1.75E + 00           2.94E--02   0.5145
  GM-CSF Signaling                                             1.74E + 00           2.94E--02   0.51156
  Clathrin-mediated Endocytosis Signaling                      2.49E + 00           2.02E--02   0.50298
  Regulation of Cellular Mechanics by Calpain Protease         1.82E + 00           2.74E--02   0.49868
  CREB Signaling in Neurons                                    2.58E + 00           1.93E--02   0.49794
  Glutamate Receptor Signaling                                 1.79E + 00           2.78E--02   0.49762
  Synaptic Long Term Potentiation                              2.14E + 00           2.31E--02   0.49434
  Antiproliferative Role of Somatostatin Receptor 2            1.73E + 00           2.78E--02   0.48094
  Agrin Interactions at Neuromuscular Junction                 1.68E + 00           2.86E--02   0.48048
  JAK/Stat Signaling                                           1.69E + 00           2.82E--02   0.47658
  Corticotropin Releasing Hormone Signaling                    2.21E + 00           2.07E--02   0.45747
  Neurotrophin/TRK Signaling                                   1.68E + 00           2.63E--02   0.44184
  P2Y Purigenic Receptor Signaling Pathway                     2.12E + 00           2.08E--02   0.44096
  Renal Cell Carcinoma Signaling                               1.65E + 00           2.53E--02   0.41745
  Insulin Receptor Signaling                                   2.03E + 00           2.01E--02   0.40803
  Melatonin Signaling                                          1.65E + 00           2.47E--02   0.40755
  FLT3 Signaling in Hematopoietic Progenitor Cells             1.60E + 00           2.53E--02   0.4048
  GNRH Signaling                                               2.05E + 00           1.96E--02   0.4018
  cAMP-mediated signaling                                      2.23E + 00           1.77E--02   0.39471
  Ephrin B Signaling                                           1.61E + 00           2.44E--02   0.39284
  Prolactin Signaling                                          1.62E + 00           2.38E--02   0.38556
  BMP signaling pathway                                        1.59E + 00           2.33E--02   0.37047
  Relaxin Signaling                                            1.98E + 00           1.83E--02   0.36234
  FGF Signaling                                                1.49E + 00           2.13E--02   0.31737
  Gap Junction Signaling                                       1.83E + 00           1.66E--02   0.30378
  Apoptosis Signaling                                          1.47E + 00           2.00E--02   0.294
  Acute Phase Response Signaling                               1.74E + 00           1.66E--02   0.28884
  G-Protein Coupled Receptor Signaling                         1.99E + 00           1.45E--02   0.28855
  Mouse Embryonic Stem Cell Pluripotency                       1.41E + 00           2.02E--02   0.28482
  Neuregulin Signaling                                         1.47E + 00           1.92E--02   0.28224
  FAK Signaling                                                1.48E + 00           1.89E--02   0.27972
  Chronic Myeloid Leukemia Signaling                           1.42E + 00           1.89E--02   0.26838
  VEGF Signaling                                               1.43E + 00           1.83E--02   0.26169
  IL-1 Signaling                                               1.42E + 00           1.83E--02   0.25986
  Sertoli Cell-Sertoli Cell Junction Signaling                 1.69E + 00           1.52E--02   0.25688
  PPARα/RXRα Activation                                        1.69E + 00           1.50E--02   0.2535
  HGF Signaling                                                1.37E + 00           1.80E--02   0.2466
  Mitochondrial Dysfunction                                    1.76E + 00           1.40E--02   0.2464
  Ephrin Receptor Signaling                                    1.70E + 00           1.43E--02   0.2431
  Role of NFAT in Cardiac Hypertrophy                          1.66E + 00           1.44E--02   0.23904
  Calcium Signaling                                            1.67E + 00           1.38E--02   0.23046
  Integrin Signaling                                           1.57E + 00           1.44E-02    0.22608
  Leukocyte Extravasation Signaling                            1.56E + 00           1.43E-02    0.22308
  Breast Cancer Regulation by Stathmin1                        1.59E + 00           1.40E--02   0.2226
  Fc Epsilon RI Signaling                                      1.30E + 00           1.71E--02   0.2223
  Nitric Oxide Signaling in the Cardiovascular System          1.36E + 00           1.60E--02   0.2176
  NGF Signaling                                                1.32E + 00           1.64E--02   0.21648
  Axonal Guidance Signaling                                    1.86E + 00           1.03E--02   0.19158
  Cardiac Hypertrophy Signaling                                1.42E + 00           1.20E--02   0.1704
  Molecular Mechanisms of Cancer                               1.58E + 00           1.03E--02   0.16274
  Colorectal Cancer Metastasis Signaling                       1.34E + 00           1.12E--02   0.15008
  Protein Kinase A Signaling                                   1.43E + 00           9.78E--03   0.139854

*Canonical signaling pathway annotation of the cortical proteins possessing BTBR:WT iTRAQ expression ratios \<1.2 or \<0.8 was created using Ingenuity Pathway Analysis. Each signaling pathway significantly populated (p \< 0.05) by at least two independent proteins are depicted. For each populated signaling pathway the −log~10~ of the enrichment probability (p-value), the enrichment ratio and the calculated hybrid score \[10 ^\*^ (enrichment ratio ^\*^ −log~10~(p-value))\] are depicted*.

###### 

**Ingenuity Canonical Signaling Pathway analysis of proteins differentially regulated in the hippocampus of aged BTBR compared to WT controls**.

  **Canonical pathways**                                    **−log(*p*-value)**   **Ratio**   **10 × Hybrid**
  --------------------------------------------------------- --------------------- ----------- -----------------
  Oxidative phosphorylation                                 1.27E + 01            1.25E--01   15.875
  Mitochondrial dysfunction                                 1.33E + 01            8.37E--02   11.1321
  GABA receptor signaling                                   5.19E + 00            1.07E--01   5.5533
  Glutamate degradation III (via 4-aminobutyrate)           3.02E + 00            1.67E--01   5.0434
  GM-CSF signaling                                          4.44E + 00            8.82E--02   3.91608
  Huntington\'s disease signaling                           6.46E + 00            5.16E--02   3.33336
  G protein signaling mediated by Tubby                     3.47E + 00            9.09E--02   3.15423
  Melatonin signaling                                       4.18E + 00            7.41E--02   3.09738
  RhoA signaling                                            4.52E + 00            6.25E--02   2.825
  Lipid antigen presentation by CD1                         2.68E + 00            1.00E--01   2.68
  Regulation of actin-based motility by rho                 3.77E + 00            6.52E--02   2.45804
  Role of NFAT in cardiac hypertrophy                       4.87E + 00            4.78E--02   2.32786
  CTLA4 Signaling in cytotoxic T lymphocytes                3.63E + 00            6.25E--02   2.26875
  TCA Cycle II (Eukaryotic)                                 2.90E + 00            7.50E--02   2.175
  Breast cancer regulation by stathmin1                     4.65E + 00            4.67E--02   2.17155
  Chemokine signaling                                       3.22E + 00            6.67E--02   2.14774
  Synaptic long term potentiation                           3.72E + 00            5.38E--02   2.00136
  Guanine and guanosine salvage I                           1.71E + 00            1.11E--01   1.8981
  CREB signaling in neurons                                 4.21E + 00            4.35E--02   1.83135
  β-alanine degradation I                                   1.71E + 00            1.00E--01   1.71
  Axonal guidance signaling                                 5.19E + 00            3.29E--02   1.70751
  GNRH signaling                                            3.51E + 00            4.58E--02   1.60758
  Actin nucleation by ARP-WASP complex                      2.65E + 00            5.97E--02   1.58205
  4-Aminobutyrate degradation I                             1.53E + 00            1.00E--01   1.53
  Superpathway of inositol phosphate compounds              3.94E + 00            3.85E--02   1.5169
  Creatine-phosphate biosynthesis                           1.32E + 00            1.11E--01   1.4652
  Pyruvate fermentation to lactate                          1.32E + 00            1.11E--01   1.4652
  D-myo-inositol-5-phosphate metabolism                     3.32E + 00            4.32E--02   1.43424
  fMLP signaling in neutrophils                             3.13E + 00            4.55E--02   1.42415
  Methylglyoxal degradation I                               1.53E + 00            9.09E--02   1.39077
  Clathrin-mediated endocytosis signaling                   3.29E + 00            4.04E--02   1.32916
  Ephrin receptor signaling                                 3.45E + 00            3.81E--02   1.31445
  Protein kinase A signaling                                3.95E + 00            3.18E--02   1.2561
  Thrombin signaling                                        3.20E + 00            3.79E--02   1.2128
  3-phosphoinositide biosynthesis                           3.10E + 00            3.87E--02   1.1997
  D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis   2.86E + 00            4.17E--02   1.19262
  D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis   2.86E + 00            4.17E--02   1.19262
  Methylmalonyl pathway                                     1.41E + 00            8.33E--02   1.17453
  Neuropathic pain signaling in dorsal horn neurons         2.50E + 00            4.59E--02   1.1475
  G beta gamma signaling                                    2.73E + 00            4.13E--02   1.12749
  nNOS signaling in neurons                                 1.95E + 00            5.77E--02   1.12515
  Signaling by rho family GTPases                           3.24E + 00            3.36E--02   1.08864
  Arginine degradation I (arginase pathway)                 1.41E + 00            7.69E--02   1.08429
  Ephrin B signaling                                        2.21E + 00            4.88E--02   1.07848
  Purine nucleotides de novo biosynthesis II                2.22E + 00            4.76E--02   1.05672
  Leptin signaling in obesity                               2.19E + 00            4.71E--02   1.03149
  Semaphorin signaling in neurons                           1.83E + 00            5.56E--02   1.01748
  Inosine-5′-phosphate biosynthesis II                      1.53E + 00            6.25E--02   0.95625
  Actin cytoskeleton signaling                              2.88E + 00            3.31E--02   0.95328
  3-phosphoinositide degradation                            2.57E + 00            3.70E--02   0.9509
  Rac signaling                                             2.43E + 00            3.91E--02   0.95013
  iCOS-iCOSL signaling in T helper cells                    2.38E + 00            3.97E--02   0.94486
  Dopamine receptor signaling                               2.17E + 00            4.17E--02   0.90489
  Molybdenum cofactor biosynthesis                          1.41E + 00            6.25E--02   0.88125
  Aldosterone signaling in epithelial cells                 2.38E + 00            3.55E--02   0.8449
  CD28 signaling in T helper cells                          2.23E + 00            3.68E--02   0.82064
  B cell receptor signaling                                 2.30E + 00            3.43E--02   0.7889
  2-oxobutanoate degradation I                              1.32E + 00            5.88E--02   0.77616
  PKCθ signaling in T lymphocytes                           2.23E + 00            3.47E--02   0.77381
  Virus entry via endocytic pathways                        1.93E + 00            3.96E--02   0.76428
  P2Y purigenic receptor signaling pathway                  2.14E + 00            3.47E--02   0.74258
  D-myo-inositol (1,4,5)-trisphosphate biosynthesis         1.48E + 00            5.00E--02   0.74
  Dopamine-DARPP32 feedback in cAMP signaling               2.25E + 00            3.21E--02   0.72225
  PI3K signaling in B lymphocytes                           2.05E + 00            3.50E--02   0.7175
  α-Adrenergic signaling                                    1.95E + 00            3.67E--02   0.71565
  Protein ubiquitination pathway                            2.41E + 00            2.96E--02   0.71336
  Gluconeogenesis I                                         1.67E + 00            4.26E--02   0.71142
  Glutamate receptor signaling                              1.69E + 00            4.17E--02   0.70473
  G-Protein coupled receptor signaling                      2.38E + 00            2.90E--02   0.6902
  IL-1 signaling                                            1.87E + 00            3.67E--02   0.68629
  Antiproliferative role of somatostatin receptor 2         1.60E + 00            4.17E--02   0.6672
  Remodeling of epithelial adherens junctions               1.53E + 00            4.29E--02   0.65637
  JAK/stat signaling                                        1.54E + 00            4.23E--02   0.65142
  Glioma signaling                                          1.84E + 00            3.54E--02   0.65136
  Role of NFAT in regulation of the immune response         2.15E + 00            3.00E--02   0.645
  Fatty acid β-oxidation I                                  1.45E + 00            4.44E--02   0.6438
  RhoGDI signaling                                          2.11E + 00            2.97E--02   0.62667
  Cardiac β-adrenergic signaling                            1.96E + 00            3.16E--02   0.61936
  Cardiac hypertrophy signaling                             2.15E + 00            2.80E--02   0.602
  Relaxin signaling                                         1.93E + 00            3.05E--02   0.58865
  Renal cell carcinoma signaling                            1.50E + 00            3.80E--02   0.57
  Calcium signaling                                         2.05E + 00            2.76E--02   0.5658
  Phospholipase C signaling                                 2.06E + 00            2.64E--02   0.54384
  Gαq signaling                                             1.80E + 00            2.92E--02   0.5256
  Gαs signaling                                             1.60E + 00            3.20E--02   0.512
  Molecular mechanisms of cancer                            2.15E + 00            2.32E--02   0.4988
  Role of tissue factor in cancer                           1.61E + 00            3.08E--02   0.49588
  Gap junction signaling                                    1.71E + 00            2.76E--02   0.47196
  p70S6K signaling                                          1.51E + 00            3.03E-02    0.45753
  Androgen signaling                                        1.60E + 00            2.76E--02   0.4416
  Gαi signaling                                             1.48E + 00            2.96E--02   0.43808
  cAMP-mediated signaling                                   1.65E + 00            2.65E--02   0.43725
  PPARα/RXRα activation                                     1.51E + 00            2.50E--02   0.3775
  Insulin receptor signaling                                1.38E + 00            2.68E--02   0.36984
  eNOS signaling                                            1.39E + 00            2.58E--02   0.35862
  Glucocorticoid receptor signaling                         1.35E + 00            2.01E--02   0.27135

*Canonical signaling pathway annotation of the hippocampal proteins possessing BTBR:WT iTRAQ expression ratios \< 1.2 or \< 0.8 was created using Ingenuity Pathway Analysis. Each signaling pathway significantly populated (p \< 0.05) by at least two independent proteins are depicted. For each populated signaling pathway the −log~10~ of the enrichment probability (p-value), the enrichment ratio and the calculated hybrid score \[10 ^\*^ (enrichment ratio ^\*^ −log~10~(p-value))\] are depicted*.

BTBR-regulated coherent protein regulation patterns
---------------------------------------------------

Along with our global analysis of protein set data from the two tissues we also investigated the predicted functional nature of the divergent expression polarity subsets of BTBR-specific proteins uniquely regulated in either the cortex or hippocampus. Using VennPlex (Figure [6A](#F6){ref-type="fig"}: Table [7](#T7){ref-type="table"}) (Cai et al., [@B8]) we were able to identify multiple groups of coherently-controlled proteins across multiple CNS tissues. Using our previously developed informatics application, *Textrous!*, we generated physiological predictions extracted from multiple databases using latent semantic analysis (Chen et al., [@B14]). Using the collective processing capacity of *Textrous!*. which generates interactive hierarchical word-clouds, we found that the tissue-unique up or down regulated sets of proteins generated quite distinct functional signatures in the cortex or hippocampus. For example, the specifically upregulated proteins in the cortex were strongly focused into activity controlling excitatory amino acid synaptic activity (Figure [S1A](#SM1){ref-type="supplementary-material"}: Table [S3](#SM5){ref-type="supplementary-material"}), while the downregulated cortical only proteins demonstrated a strong link to a reduction of protein kinase activity (Figure [S1B](#SM1){ref-type="supplementary-material"}: Table [S4](#SM6){ref-type="supplementary-material"}). With respect to the hippocampus, the upregulated protein set appeared to be linked to increases in heat-shock factors and synaptic pathophysiology (Figure [S2A](#SM2){ref-type="supplementary-material"}: Table [S5](#SM7){ref-type="supplementary-material"}), while the downregulated hippocampal protein set suggested a reduction in oligodendrocyte generation and CNS myelination (Figure [S2B](#SM2){ref-type="supplementary-material"}: Table [S6](#SM8){ref-type="supplementary-material"}).

![**Identification of coherent regulatory protein signatures in BTBR CNS tissues**. Vennplex diagram analysis of the upregulated (BTBR:WT iTRAQ ratio \> 1.2) or downregulated (iTRAQ ratio \< 0.8) proteins in both the hippocampus and cortex are depicted **(A)**. A small coherently-regulated protein subset across both tissues was evident and comprised a focused protein set strongly linked to human ASD-like conditions **(B)**. *Textrous!*-based collective processing interrogation of the coherently-regulated BTBR protein set revealed, in the resultant hierarchical word-cloud, a strong potential role of skeletal modeling activity in this protein set **(C)**. This skeletal signaling dependence of ASD was confirmed using the individual processing module of *Textrous!* **(D)**. In this heatmap output correlation strength between protein and functional term is indicated by the intensity of the teal-colored blocks.](fnagi-06-00225-g0006){#F6}

###### 

**VennPlex Venn diagram analysis of up and downregulated proteins across the cortex and hippocampus of BTBR mice compared to WT controls**.

  **Protein**   **Cortex up**   **Cortex down**   **Hippo up**   **Hippo down**
  ------------- --------------- ----------------- -------------- ----------------
  PRRT2         1.951168338                       2.381953722    
  DYNLL1        1.672920918                       1.737545789    
  DBNL          1.626693344                       1.24548243     
  AP3B2         1.581785753                       1.789312776    
  VAT1L         1.391942674                       1.401775589    
  WDR33         1.379833997                       2.510567518    
  GOLGA2        1.292500223                       1.60040989     
  LANCL1        1.279121599                       1.320074872    
  ME3           1.270939623                       1.62730561     
  ITSN1         1.269638936                       1.774926636    
  CEP290        1.238621608                       1.454207016    
  PCYOX1L       1.209317219                       1.860882083    
  ERMN                          −1.243267187                     −1.500264003
  CSRP1                         −1.365689412                     −1.509867503
  DBI                           −1.496288514                     −2.056916039
  NUCB1                         −1.631205729                     −3.561025937
  EIF5A         1.517756095                                      −1.65673365
  MMAA          1.391228352                                      −1.887879989
  PTPN11        1.247745108                                      −3.093767449
  ZXDB          1.214676409                                      −1.393599577
  SLC17A7       1.204082729                                      −1.315805498
  DPYSL4        1.195193712                                      −1.314442062
  OAT                           −1.307905257      1.362629072    
  Ptcd          1.828557315                                      
  PCBP2         1.792502849                                      
  QDPR          1.7625157                                        
  SRSF4         1.533013648                                      
  ADCY2         1.511246891                                      
  NDUFS4        1.47998035                                       
  SLC9A3R1      1.473396618                                      
  LETM1         1.455678341                                      
  PRDX3         1.44243043                                       
  IDH2          1.441010435                                      
  EXOC5         1.41342868                                       
  HNRNPUL2      1.405691244                                      
  PTCD1         1.371753507                                      
  DDX5          1.365841661                                      
  PPP1R9B       1.346708939                                      
  DPP6          1.340020376                                      
  LAP3          1.303333413                                      
  KCNAB2        1.296085587                                      
  SLC12A5       1.252190507                                      
  HOOK3         1.250023514                                      
  COX5A         1.247002966                                      
  WDR1          1.244912709                                      
  GRM2          1.243617897                                      
  CAB39         1.2340405                                        
  RTN3          1.233971862                                      
  TF            1.233243832                                      
  FBXO41        1.231290747                                      
  RAB7A         1.226744118                                      
  RTN4          1.216638369                                      
  TCP1          1.215498024                                      
  PRKAR2B       1.215235782                                      
  CCT3          1.20748828                                       
  PRDM5         1.198502382                                      
  COQ9                          −1.24961385                      
  CLDN11                        −1.260614004                     
  NCALD                         −1.266374541                     
  F5                            −1.269955566                     
  EXOC6B                        −1.275380087                     
  CTTN                          −1.287911813                     
  VBP1                          −1.361766656                     
  PICALM                        −1.466374966                     
  CAPNS1                        −1.756445493                     
  TOMM20                        −1.819905488                     
  MAPK3                         −1.918813356                     
  NUDC                                            1.732009523    
  RAP2B                                           1.726355193    
  KIF2A                                           1.663032474    
  SETDB1                                          1.648556725    
  ATP6V1D                                         1.640964877    
  SYNGR1                                          1.58532711     
  DPYSL3                                          1.582802831    
  NCAN                                            1.571585688    
  CTNND2                                          1.562506309    
  CNRIP1                                          1.554254382    
  UTP20                                           1.544855143    
  ME1                                             1.478800627    
  PFN1                                            1.477145399    
  PPME1                                           1.455765369    
  APP                                             1.455465641    
  LANCL2                                          1.455132031    
  GNAQ                                            1.453050806    
  ARPC5L                                          1.451224208    
  PRDX2                                           1.448929334    
  CYFIP1                                          1.432347642    
  HSPA2                                           1.431503207    
  SFPQ                                            1.427372534    
  TXLNG                                           1.42119969     
  GRB2                                            1.4157442      
  CPNE6                                           1.414165286    
  PDXP                                            1.410098436    
  GNB2                                            1.408516442    
  GLOD4                                           1.391614359    
  OXR1                                            1.380069445    
  VAMP2                                           1.373709575    
  HSPA1A                                          1.373028035    
  HSPA1B                                          1.373028035    
  PSD3                                            1.371411227    
  BSG                                             1.369172074    
  PFN2                                            1.368469072    
  ATP5J2                                          1.368321641    
  GNB1                                            1.366417736    
  DLG4                                            1.363981591    
  SH3GLB2                                         1.36363306     
  KTN1                                            1.362629072    
  RAB3A                                           1.362173026    
  CCT7                                            1.3567651      
  SDHC                                            1.347654394    
  BCAN                                            1.342898167    
  HSPH1                                           1.337373319    
  ADD2                                            1.336930818    
  AP2A2                                           1.335723865    
  DYNLL2                                          1.322647505    
  GDA                                             1.312825433    
  TKT                                             1.3105561      
  COX7A2                                          1.308575621    
  SNCA                                            1.305570043    
  BAIAP2                                          1.303596608    
  SH3BGRL3                                        1.302583328    
  NPM1                                            1.301978732    
  NIPSNAP1                                        1.299090793    
  ARPC4                                           1.296939524    
  NAPA                                            1.292138971    
  CALB1                                           1.290893833    
  CAMKV                                           1.286413462    
  COX6C                                           1.286388519    
  COX5B                                           1.285714649    
  NDUFA9                                          1.285358088    
  ATP6V0D1                                        1.275603048    
  NSFL1C                                          1.274526051    
  LDHA                                            1.269135901    
  ATP6V1F                                         1.266693513    
  CLTB                                            1.265664013    
  SRSF4                                           1.261593119    
  LRGUK                                           1.260891479    
  NDUFS8                                          1.260447912    
  PPP2CB                                          1.259397109    
  COX4I1                                          1.256849924    
  CAMK2D                                          1.256848229    
  DNAJC6                                          1.255985647    
  COL6A2                                          1.253698992    
  CRYM                                            1.251866833    
  PPP3CA                                          1.249125255    
  SLC2A1                                          1.24839376     
  PPFIA3                                          1.244596343    
  CAMK2A                                          1.241519397    
  SYP                                             1.237859198    
  AP2B1                                           1.237413188    
  USP24                                           1.233820239    
  FABP5                                           1.233314773    
  SEPT9                                           1.226916013    
  EHD1                                            1.226344591    
  CAP2                                            1.223807885    
  SLC25A3                                         1.221941931    
  CAMK2B                                          1.22058499     
  PTGES3                                          1.216665914    
  PRDX1                                           1.215985447    
  ATP5I                                           1.215521395    
  ATIC                                            1.213849668    
  GSTM5                                           1.213704207    
  NDUFS7                                          1.211966939    
  DCLK1                                           1.207992461    
  GPD1L                                           1.207286149    
  HNRNPL                                          1.205847041    
  NAPB                                            1.202833155    
  RTN4                                            1.201798491    
  PCSK1N                                                         −1.245474191
  WDR7                                                           −1.245967263
  MAG                                                            −1.248958157
  DDB1                                                           −1.255013637
  MOBP                                                           −1.256321905
  GAD2                                                           −1.26014124
  INA                                                            −1.265874043
  TPT1                                                           −1.268669401
  IDH3G                                                          −1.270175029
  PCCB                                                           −1.272883353
  MAPRE2                                                         −1.274095945
  MRPS36                                                         −1.275342647
  MARCKS                                                         −1.280485807
  PSMC6                                                          −1.281124693
  ABAT                                                           −1.283265073
  NTM                                                            −1.284285221
  CA2                                                            −1.284359839
  HPCAL1                                                         −1.284463003
  MOG                                                            −1.295178624
  PSMA6                                                          −1.297701354
  SDHA                                                           −1.300775393
  COPB1                                                          −1.300938943
  NONO                                                           −1.301095086
  TUFM                                                           −1.311237761
  ADSS                                                           −1.311542644
  IGSF8                                                          −1.312784192
  COX5A                                                          −1.313555144
  UQCRFS1                                                        −1.316410553
  CKB                                                            −1.318123142
  PIP4K2B                                                        −1.324477494
  NEFM                                                           −1.330302859
  PSMD6                                                          −1.330311752
  NEFL                                                           −1.344530231
  NDUFA8                                                         −1.348309239
  BIN1                                                           −1.354260702
  PTMS                                                           −1.379162453
  PHB2                                                           −1.381012946
  NDUFS2                                                         −1.382654847
  DSTN                                                           −1.396469687
  CCT5                                                           −1.396711507
  S100B                                                          −1.403153034
  CLASP2                                                         −1.403192685
  EPB41L1                                                        −1.419486383
  PFKL                                                           −1.424253294
  PSAP                                                           −1.429458675
  CPLX1                                                          −1.437904339
  SERPINA3K                                                      −1.462482626
  AHSA1                                                          −1.482509362
  SET                                                            −1.494218612
  ATL1                                                           −1.49652324
  PRKACB                                                         −1.501341659
  NME2                                                           −1.502355851
  ITPKA                                                          −1.515605888
  NCS1                                                           −1.519434163
  EEF1A1                                                         −1.528884517
  PLCB1                                                          −1.530645112
  ENPP6                                                          −1.542384655
  SYNE1                                                          −1.544411246
  PCP4                                                           −1.554348855
  MBP                                                            −1.583600552
  NCEH1                                                          −1.612308156
  ACSL6                                                          −1.612342183
  GLO1                                                           −1.659621805
  PPP1R1B                                                        −1.668571078
  HSD17B10                                                       −1.719780931
  SIRT2                                                          −1.776727737
  GPHN                                                           −1.810243901
  MORC1                                                          −1.853643692
  SLC6A11                                                        −1.877132951
  PDHX                                                           −1.878732243
  PTK6                                                           −1.89800334
  DPYSL5                                                         −1.903465278
  HPRT1                                                          −2.333095423

*For each specific protein studied fold change values, indicated in the table below, were generated from the iTRAQ expression ratios of (\>1.2 or \<0.8) proteins differentially regulated in the BTBR tissues \[Cortex, Hippocampus (Hippo)\] compared to WT*.

In addition to our global data set informatics interpretation we also sought to investigate the function of coherently-regulated groups of BTBR-associated proteins observed across multiple tissues. We therefore focused on the subset of proteins (12 upregulated; 4 downregulated: Table [7](#T7){ref-type="table"}) coherently altered in a BTBR-specific manner in both the cortex and hippocampus (Figure [6B](#F6){ref-type="fig"}). To explore the potential functional connection between these select proteins we applied our novel informatic platform *Textrous!* (Chen et al., [@B14]). *Textrous!* allows the extraction of functional data, using latent semantic analysis (LSA), from even the smallest of datasets. *Textrous!* is a unique LSA tool as it possesses two forms of functional data output, i.e., collective and individual processing. Collective processing of the coherent BTBR protein set results in the creation of a hierarchical word-cloud revealing a strong and novel link between the BTBR ASD phenotype and N-WASP (neuronal Wiskott--Aldrich Syndrome protein) mediated activity (Figure [6C](#F6){ref-type="fig"}: Table [8](#T8){ref-type="table"}). In addition there was a second, less strong demonstration of the importance of inherited genomic activity in ASD phenotypes. The individual processing mode in *Textrous!* also investigates the strongest individual protein-term relationships within a specific protein subset (Figure [6D](#F6){ref-type="fig"}). Again with this distinct analytical output we observed a strong relationship between cytoskeletal remodeling activity (f-actin, scaffolding, n-wasp, filopodia) and proteins such as Itsn1 (intersectin 1), Ap3b2 (adaptor-related protein complex 3, beta 2 subunit), Dbnl (drebrinlike) and Ermn (Ermin, ERM-like protein) with the BTBR phenotype. Interestingly other tight relationships between BTBR coherently-regulated factors were found, e.g., myelin-associated activity \[Lancl1 (LanC bacterial lantibiotic synthetase component C)-like 1 and Ermn\] and inherited neuronal atrophy and impairment \[Prrt2 (proline-rich transmembrane protein **2**) and Cep290 (centrosomal protein 290)\] (Figure [6D](#F6){ref-type="fig"}).

###### 

***Textrous!*-based collective analysis of coherently-regulated BTBR-specific proteins**.

  **Word**              **Cosine similarity**   ***Z*-score**   ***p*-Value**
  --------------------- ----------------------- --------------- ---------------
  Motor                 0.524476314             1.869598279     0.030741909
  Nonsense              0.478414897             1.693752796     0.045132642
  Atrophies             0.4700895               1.661969501     0.048256387
  Gtpases               0.468206051             1.65477919      0.048962249
  Exons                 0.466743056             1.649194013     0.049573817
  Growth-associated     0.455961506             1.608034038     0.053917589
  Inherited             0.455845768             1.607592194     0.053917589
  Gtpase                0.455708175             1.607066915     0.054027184
  Autosomal             0.453900108             1.600164382     0.054799292
  Polymerization        0.453672232             1.599294435     0.054910301
  Optic                 0.444664336             1.564905613     0.058791455
  Exon                  0.437675556             1.538225034     0.062024307
  Gtp-binding           0.435679912             1.5306064       0.062884696
  Maps                  0.427384101             1.498936057     0.066936816
  Bundles               0.426675363             1.496230358     0.067326828
  Disabilities          0.423470554             1.483995579     0.06890446
  Gdi                   0.419726975             1.469703976     0.070780877
  Brothers              0.419534775             1.46897023      0.070916395
  Movement              0.417518799             1.461273977     0.072007721
  Acuity                0.417184158             1.45999644      0.072145037
  Cytoskeleton          0.414147875             1.448405032     0.073808525
  n-wasp                0.412898356             1.443634832     0.074369488
  Frameshift            0.411123648             1.436859653     0.075358997
  Recessive             0.409375594             1.430186227     0.07635851
  Wiskott-aldrich       0.407779814             1.424094126     0.077223236
  Actin                 0.406644694             1.419760659     0.077803841
  Wasp                  0.405802073             1.416543842     0.078241464
  Gtpase-activating     0.402282931             1.403109057     0.080308419
  Recycling             0.395770067             1.378245348     0.084101644
  Reorganization        0.391991869             1.363821581     0.086283783
  Prenylation           0.389968302             1.356096352     0.087549584
  Splice                0.388453273             1.350312529     0.088507991
  Missense              0.388195935             1.349330109     0.088668483
  Streaming             0.387806369             1.347842888     0.088829191
  Apparatus             0.3874916               1.346641219     0.088990116
  Pericentriolar        0.387010855             1.344805911     0.089312617
  Families              0.386042261             1.341108175     0.089960226
  Plexiform             0.385574635             1.339322953     0.090285336
  Polysomes             0.383798601             1.332542712     0.091265902
  Guanosine             0.383107191             1.329903161     0.091759136
  Splicing              0.382666221             1.328219703     0.092089053
  Cytoskeletal          0.381993528             1.325651608     0.092419849
  Mutational            0.381893517             1.325269803     0.092585576
  Coiled-coil           0.381550118             1.323958833     0.092751522
  gaps                  0.380853905             1.321300948     0.093250682
  Depolymerizing        0.380444571             1.319738261     0.093417509
  Intellectual          0.378479462             1.312236202     0.094760067
  Mutations             0.378323187             1.311639602     0.094760067
  Protrusions           0.377199886             1.307351254     0.095606356
  Neurofibromin         0.376699229             1.305439931     0.095946424
  Actin-binding         0.375976678             1.302681498     0.096287381
  Atrophy               0.375377983             1.3003959       0.096800485
  Dynamics              0.373862886             1.29461182      0.097660115
  Pigmentary            0.373853033             1.294574204     0.097660115
  Neuron                0.370913941             1.283353835     0.099746038
  Multidisciplinary     0.369651835             1.27853558      0.100448528
  Destination           0.369566192             1.278208627     0.100624713
  Cilia                 0.368620901             1.274599856     0.101154621
  Gtp-dependent         0.367048826             1.268598253     0.102220532
  Phosphatidic          0.366734218             1.267397195     0.102577645
  Identification        0.366608729             1.266918125     0.102577645
  Disability            0.365764506             1.263695196     0.103115013
  Muscular              0.365741802             1.26360852      0.103115013
  Ciliary               0.364952202             1.260594116     0.103654424
  Meshwork              0.364710238             1.259670389     0.103834681
  Partners              0.364390606             1.258450149     0.104195878
  Inheritance           0.364260066             1.257951798     0.104195878
  Scanning              0.363734162             1.255944089     0.104557985
  f-actin               0.363367304             1.254543564     0.10473938
  Beta-galactoside      0.36316993              1.253790062     0.104921003
  Anonymous             0.361144496             1.2460577       0.106382198
  Protrusion            0.359889734             1.241267484     0.107302874
  Sialyltransferase     0.359831442             1.241044947     0.107302874
  Neurofibromatosis     0.359791096             1.24089092      0.107302874
  Lipofuscin            0.359746522             1.240720753     0.107302874
  Radixin               0.35878958              1.237067503     0.108043541
  Proteins              0.358631641             1.236464548     0.108229282
  Squid                 0.358474059             1.23586296      0.108229282
  Screen                0.356102317             1.226808525     0.109911295
  Filopodia             0.355914644             1.226092057     0.110099338
  Extensions            0.355265349             1.223613288     0.110476114
  Lowe                  0.355018906             1.222672462     0.110664848
  Pre-mrna              0.354335273             1.220062601     0.111232437
  Leber                 0.354284348             1.219868188     0.111232437
  Counseling            0.354132651             1.219289065     0.111422096
  x-linked              0.354046801             1.218961323     0.111422096
  Cones                 0.353920096             1.218477608     0.111611986
  Contig                0.353576868             1.217167292     0.111802108
  Cryomicroscopy        0.35310173              1.215353389     0.112183046
  Amaurosis             0.353046083             1.215140949     0.112183046
  Methanothermobacter   0.352545212             1.21322881      0.11256491
  Neurofibromas         0.35222224              1.211995824     0.11275619
  Endocytic             0.352220725             1.211990038     0.11275619
  Pumping               0.351073392             1.207609946     0.113523631
  Tail                  0.350586481             1.205751097     0.113908745
  Dynamin               0.350367829             1.204916365     0.114101651
  Syndrome              0.349521708             1.20168619      0.114681764
  Endosomes             0.347991562             1.195844656     0.11584828
  Blindness             0.34724489              1.19299414      0.116434687
  Visual                0.347190286             1.192785679     0.116434687

*Cosine similarity scores, Z-scores and probability values (p-Value) were calculated using collective processing of the 16 coherently-regulated BTBR-specific proteins in the cortex and hippocampal datasets*.

Discussion {#s4}
==========

In the present study we evaluated the behavior, synaptic protein alterations and targeted proteomic signatures in the hippocampus and cortex of 15 month old BTBR and WT mice to determine whether the ASD-like phenotype of BTBR mice was resistant to neuronal aging. Thus, we assessed both the behavioral phenotype and proteomic profiles between aged ASD-like mice (abnormal CNS) and aged wild type mice (with a relatively normal CNS). We found that several neurosynaptic proteins were significantly increased in both the hippocampus and cortex of the aged ASD-like mice in comparison to the aged wild type. In particular, the phosphorylated form of the pre-synaptic marker synapsin 1, and the post-synaptic marker spinophilin were increased in both the aged BTBR hippocampus and cortex; PSD95 was significantly elevated in aged BTBR hippocampus. Aged BTBR mice still presented a behavioral phenotype typically observed in young autistic mice, suggesting that the physiological actions underlying the ASD-like condition of the BTBR mice is relatively resistant to aging.

The maintenance of the ASD-phenotype into advanced age in BTBR mice is intriguing because in the normal developing CNS synapses are overproduced but then become pruned in response to neuronal activity during post-natal development (Petit, [@B68]; Cohen and Greenberg, [@B15]; Ebert and Greenberg, [@B25]). It is proposed that autism is caused by dysregulation of the machinery controlling synaptic messenger RNA translation leading to increased synthesis of synaptic proteins and lack of synaptic pruning, in turn inducing a hyperconnectivity and over-reinforcement of neuronal circuits. In fact it is one of the hallmark characteristics of ASD observed in the brains of both mouse models and humans with ASD (Kelleher and Bear, [@B47]; Gkogkas et al., [@B32]). Fragile X syndrome, for example which is the leading cause of inherited intellectual disability and ASD (Bhakar et al., [@B4]), is caused by mutations in FMR1 gene resulting in decreased expression of fragile X mental retardation protein (FMRP). This protein modulates the rate of translational elongation of mRNAs that encode synaptic proteins (Darnell et al., [@B21]). A decrease in FMRP impairs regulation of synaptic protein expression (Bhakar et al., [@B4]) and post-natal synapse elimination (Harlow et al., [@B34]).

As increased synaptic marker expression is associated with the autistic-like mouse phenotype it is not surprising that we found that the BTBR T + tf/j mice maintained their reduced social behavior into old age (Figure [1](#F1){ref-type="fig"}). This is consistent with the limited human literature that found that social impairments in individuals with ASD persist into adulthood (Ballaban-Gil et al., [@B3]; Szatmari, [@B88]; Howlin and Moss, [@B41]). Although increased synaptic markers have been found to be deleterious for the developing CNS, it is possible that the increased synapses and hyperconnected neuronal circuits be an effective advantage in the aging process where typically nervous system connectivity is degraded through accumulated damage. BDNF and TrkB mRNAs are localized in dendritic spines, thus age-related spine density decreases in older individuals suggest a link between BDNF and TrKB mRNA expression and impaired synaptic connections with aging (Tapia-Arancibia et al., [@B89]). Indeed decreases in both BDNF and TrkB expression have been documented in the hippocampus and in the neocortex during physiological aging (Phillips et al., [@B69]; Murray et al., [@B61]; Connor et al., [@B16]; Ferrer et al., [@B27]; Quartu et al., [@B73]; Hock et al., [@B37]; Holsinger et al., [@B39]; Fahnestock et al., [@B26]; Romanczyk et al., [@B75]; Tapia-Arancibia et al., [@B89]; Zhao et al., [@B93]).

We found that levels of mature BDNF were significantly decreased in the aged BTBR hippocampus and cortex compared with the aged WT (Figures [2A](#F2){ref-type="fig"}, [3A](#F3){ref-type="fig"}), suggesting an accelerated aging phenomena, but did not find a significant change in the overall level of active TrkB receptor (Figures [2D](#F2){ref-type="fig"}, [3D](#F3){ref-type="fig"}), in the BTBR mice. In addition, we also found that there was a non-significant trend for the increase in the expression in both cortical and hippocampal levels of Akt1, one of the most important downstream targets of TrkB signaling. Thus, via a potentially complex compensatory mechanism, the BTBR mice may have increased their BDNF signaling efficiency and downstream signal transduction capacity compared to WT mice.

Our findings of reduced BDNF in both the hippocampus and cortex in old BTBR mice compared to old WT mice despite seemingly intact memory functioning may be related to this efficiency potentiation of the BDNF-TrkB system in the BTBR mice. These effects may be related to changes in endocytic proteins such as Itsn1, Golga2 and Ap3b2 (Table [7](#T7){ref-type="table"}) that may affect the signaling dynamics of the TrkB receptor (Mattson et al., [@B54]). In addition it is possible that the elevated levels of various synaptic markers served to protect the aging BTBR brain against age-related declines in cognition often associated with decreased levels of BDNF.

Given the complexity of the ASD, it is unlikely that BDNF signaling and various neuronal cell markers are the only protein products altered in the presence of ASD; thus we performed global quantitative iTRAQ proteomics, coupled to advanced bioinformatics in order to gain a comprehensive, systems-level understanding of potential changes in aged BTBR mice compared to WT counterparts. With respect to current relevant literature we discovered that many of these proteins differentially regulated in the brain of the old BTBR mice demonstrated strong correlations with those altered in humans with neurodevelopmental disabilities (Table [S7](#SM9){ref-type="supplementary-material"}). Nearly twenty percent of the coherently-regulated proteins across the hippocampus and cortex of aged BTBR mice also are strongly linked to human ASD phenotypes, suggesting that future investigation of the remaining factors may prove extremely fruitful for autism-related research (Figure [6B](#F6){ref-type="fig"}). With respect to the highly-focused, coherently-regulated protein set (Figure [6B](#F6){ref-type="fig"}: Table [7](#T7){ref-type="table"}) Prrt2 was coherently altered in both the hippocampus and cortex of aged BTBR mice compared to aged WT (Table [7](#T7){ref-type="table"}). Alterations in activity of Prrt2 have been found in the frontal cortex of individuals with autism (Ji et al., [@B44]) and have also been genetically-associated with ASD (Weber et al., [@B90]). Vat1l was up-regulated in both the hippocampus and cortex of the old BTBR mice.

We performed functional informatics data clustering to gain a wider appreciation of the signaling phenotype present in aged BTBR mice. Using GO term annotation it was evident in the cortex that considerable alterations in ER (endoplasmic reticulum), vesicular transport, cytoskeletal remodeling, and energy generation were apparent (Figures [4E,F](#F4){ref-type="fig"}). The functional GO term clustering of differentially expressed proteins in the BTBR hippocampus also indicated a role of energy generation, neurotransmitter release and synaptic activity but did not display a robust skeletal remodeling component (Table [2](#T2){ref-type="table"}). We also employed KEGG and Ingenuity Canonical Signaling pathway analysis for the differentially-regulated cortex and hippocampal protein sets. At this higher level of functional interrogation (compared to GO term clustering) we also observed a subtle divergence in tissue behavior, i.e., cortical KEGG pathway analysis demonstrated a strong bias toward energy metabolic and neurotrophic/neuroprotective mechanisms (Figure [5A](#F5){ref-type="fig"}) while the hippocampus demonstrated a more degenerative phenotype associated with metabolic instabilities and calcium management factors (Figure [5B](#F5){ref-type="fig"}). Interestingly and to highlight the need for multidimensional informatics analyses for physiological interpretation, the canonical signaling pathway analysis of both tissue datasets revealed additional processes that could affect the ASD phenotype, i.e., the prominence of cytokine signaling activity in the cortex and the identification of the potential role of melatonin function in both CNS tissues (Figures [5C,D](#F5){ref-type="fig"}).

To further reinforce the importance of applying unbiased informatics for the analysis of complex data associated with a highly nuanced phenotype such as ASD we found that analysis of different subgroups of the data yielded interesting, tissue-specific insights into the effects of aging on ASD. Using our novel *Textrous!* platform we were able to identify differential tissue activity, i.e., enhanced glutamatergic cortical activity coincident with attenuated kinase signaling (Figure [S1](#SM1){ref-type="supplementary-material"}). These cortical changes occurred contemporaneously with an elevation of hippocampal protein misfolding/aggregation coincident with an attenuated CNS myelination and oligodendrocyte functionality (Figure [S2](#SM2){ref-type="supplementary-material"}). Both of these hippocampal processes have been recently associated with dysfunctional brain development (Mitew et al., [@B57]).

When approaching complex issues such as ASD with a systems-biology approach it is important to maintain this concept of multiple levels of protein interaction, function and hierarchical architecture, i.e., functions can be tissue specific, expression polarity specific while also existing contemporaneously at a level above tissue-or polarity-dependence. For example we found that inspection of the coherently-regulated multi-tissue protein set revealed an exciting and potentially novel functional association of neuronal Wasp (Wiskott-Aldrich syndrome protein) activity and ASD (Figures [6C,D](#F6){ref-type="fig"}). To our current knowledge this is the first example of such a functional correlation, however it is relatively simple to predict that the molecular activities of this skeletal remodeling factor could impact a disorder such as ASD in which a less synaptically plastic neurological system is present.

In conclusion, we found that both the social behavioral phenotype and the CNS proteomic profile of this ASD model are relatively age-resistant. Aged BTBR mice possessed elevations in hippocampal and cortical synaptic markers that likely play a role in the etiology of the autistic-like phenotype. Low levels of BDNF have been found inconsistently in the ASD literature but more consistently in the aging and Alzheimer Disease literature (Chadwick et al., [@B12]). Diminished mature BDNF in the aged BTBR hippocampus/cortex were seen along with complementary alterations in the downstream signaling pathways compared to WT aged mice. These findings in-part reinforce the potential long-term neuroprotective capacity of the ASD phenotype with respect to cognitive aging. It is therefore interesting to posit that despite lower levels of neurosynaptic plasticity that the more robust and reinforced neuronal network in ASD phenotypes may indeed act prophylactically over long periods of time compared to normal CNS networks that degrade due to unrepaired damage and synaptic loss. The complex proteotype of the BTBR mice revealed molecular and functional signatures highly reminiscent of those found in humans with neurodevelopmental disabilities including ASD. Many of these identified processes play a role in neurodevelopment based on studies in murine models, and give more evidence for proteins that are playing a role in neuroprotection allowing for maintenance of cognition in the aged BTBR mice. Therefore, it is possible that the elevated levels of various synaptic markers and proteins identified proteomically such as Picalm, Itsn1, Mobp, Ina, as well as signaling actions involving Wasp functionality served to protect the aging BTBR brain against age-related declines in cognition often associated with decreased BDNF. In the current study we observed a robust maintenance of cognitive ability despite advanced age that may be due to unique neurosynaptic architecture and activity in the ASD phenotype. The role of the associated proteins and synaptic markers provide a foundation for further investigation into this intriguing mechanism.
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**Collective *Textrous!* analysis of differentially-regulated cortical protein subsets**. Functional hierarchical word-clouds were generated from the upregulated (BTBR:WT iTRAQ ratio \> 1.2) (A) and downregulated (BTBR:WT iTRAQ ratio \< 0.8) cortical protein data sets.
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**Collective *Textrous!* analysis of differentially-regulated hippocampal protein subsets**. Functional hierarchical word-clouds were generated from the upregulated (BTBR:WT iTRAQ ratio \>1.2) (A) and downregulated (BTBR:WT iTRAQ ratio \< 0.8) hippocampal protein data sets.
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BDNF

:   brain derived neurotrophic factor

BTBR

:   black and tan, brachyuric

ASD

:   autism spectrum disorder.
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